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1  Zusammenfassung  
Einleitung: Leberregeneration erfordert die Regeneration des Parenchyms und des 
Gefäßbaumes. Bisher stand die Regeneration des Leberparenchyms im Fokus des 
wissenschaftlichen Interesses, nicht zuletzt aufgrund der technischen Limitationen 
die Regeneration des Gefäßbaumes quantitativ zu beschreiben.  Daher zielt diese 
Untersuchung darauf ab, die Techniken zur Quantifizierung der vaskulären 
Leberregeneration am Mausmodell zu verbessern.  
Ziele: Wir definierten vier Teilziele: Etablieren einer intraoperative Monitoringtechnik 
zur Erfassung der Hämodynamik der Leber in der Maus, Etablieren eines 
Arbeitsablaufes zur Kontrastierung einer Mausleber, Bildgebung mittels µCT und 3D-
Rekonstruktion des Gefäßbaumes, Entwicklung eines Verfahrens zur 
computerunterstützten Quantifizierung des regenerierenden Gefäßbaumes und die 
Untersuchung der parenchymalen und vaskulären Leberregeneration nach 
Modulation der CXCR4-CXCR7-SDF-1 Achse mit Hilfe der neu entwickelten 
Verfahren.  
Methoden und Ergebnisse: Im ersten Schritt wurde die technisch schwierige 
MonitoringTechnik am Mausmodell etabliert um hämodynamische Parameter der 
Leber wie den portalen und leberarteriellen Blutfluß und den portalen Druck zu 
messen. Diese Parameter wurden sowohl in Normaltieren, während einer selektiven 
partiellen Ischämie und vor, während und im Verlauf nach einer 70%igen partiellen 
Hepatektomie gemessen. Die Ergebnisse lassen erkennen, dass die angewandte 
Monitoringtechnik hinreichend empfindlich ist, um kleine Veränderungen im portalen 
Druck und der portalen Flussrate festzustellen. 
Im zweiten Schritt wurde ein Verfahren zur Visualisierung und Quantifizierung des 
Gefäßbaumes entwickelt. Der Gefäßbaum wurde durch die Injektion eines 
Silikonpolymers kontrastiert. Anhand der hämodynamischen Parameter aus den 
MonitoringExperimenten wurde die optimale Flussrate zur Injektion des Polymers 
festgelegt (0.2ml/min). Die kontrastierten Lebern wurden explantiert und im µCT 
gescannt. Mit Hilfe eines schwellenwertbasierten Algorithmus (Imalytics Preclinical 
Software) wurden die Gefäßbäume 3D rekonstruiert und ausgewählte Parameter  wie 
z.B. die maximale Gefäßlänge und der Radius der rechten unteren Portalvene, 
interaktiv vermessen. 
Im dritten Schritt wurde das Wachstumsmuster der Leber im Rahmen der 
Regeneration betrachtet. Dazu wurde eine Serie von portalvenös und lebervenös 
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kontrastierten Präparaten zu verschiedenen Zeitpunkten nach 70%PH (unmittelbar, 2, 
3 und 7 Tage, n=3/Gruppe) per µCT untersucht. Mit Hilfe des 
Schwellenwertverfahrens wurden die Gefäßbäume 3D-rekonstruiert und selektiv 
vermessen. Zusätzlich erfolgte die Segmentierung und 3D-Rekonstruktion von 
Leberterritorien und Gefäßbäumen mit Hilfe des Programms HepaVision um das 
Lebervolumen und kumulative Gefäßparameter (z.B. Gesamtlänge der Gefäße) 
berechnen zu können. Wie zu erwarten korrelierten Lebervolumen und Lebergewicht, 
sodass im Weiteren das Lebervolumen als Maß der parenchymatösen Regeneration 
verwendet wurde. Basierend auf der Gefäßgeometrie wurde eine Reihe von 
kumulativen Gefäßparametern zur Quantifizierung des Gefäßbaumes berechnet:  
Gesamtlänge und Gesamtgefäßvolumen. Gefäßdichte, (Gesamtlänge/ Lebervolumen 
und vaskulärer Volumenanteil) wurden erhoben. Mit Hilfe des HepaVision-
Programms wurde ein virtuelles Resektionsmodell entwickelt, um den Effekt der 
resektionsbedingten portalen Hypertension auf die Gefäßparameter zu eliminieren. 
Die quantitativen Gefäßparameter nach virtueller Resektion wurden mit denen am 
siebten Tag nach chirurgischer Resektion verglichen. Obwohl bei qualitativer 
Betrachtung eine scheinbar homogene 3D-Größenzunahme zu beobachten war, 
konnten die quantitativen Gefäßparameter die Hypothese des isotropen Wachstums 
des  Leberparenchyms und der Gefäßstrukturen nicht bestätigen. 
Viertens wurden die Techniken der Silikoninjektion und µCT-Bildgebung angewendet 
um die parenchymatöse und vaskuläre Regeneration nach Modulation des CXCR4-
Signalwegs zu quantifizieren. Die Leberregeneration konnte durch die Gabe von 
AMD3100, einem CXCR4-Antagonisten, nicht beeinflusst werden. Jedoch wurden die 
parenchymale Leberregeneration und das Gefäßwachstum durch die Gabe von 
TC14012, das sowohl als CXCR4-Antagonist als auch als CXCR7-Agonist agiert, 
beeinträchtigt. 
Zusammenfassung: Im Rahmen dieser Arbeit zwei technisch schwierige chirurgische 
Methoden etabliert: zum einen die Monitoringtechnik zur Beurteilung 
hämodynamischer Auswirkungen der  partiellen Hepatektomie und zum anderen der 
Arbeitsablauf zur Visualisierung und Quantifizierung der Gefäßbäume  mittels  µCT. 
Es wurden quantitative Parameter zur Beschreibung des Gefäßwachstums 
identifiziert und mit deren Hilfe der Zusammenhang zwischen parenchymatöser und 
vaskulärer Regeneration untersucht. Zum Schluss wurden die beschriebenen 
Gefäßparameter genutzt, um das verzögerte und geminderte Gefäßwachstum nach 
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Modulation der CXCR4-CXCR7-SDF-1-Achse im Mausmodell nach 70%iger 
partieller Hepatektomie zu quantifizieren. 
Schlußfolgerung Insgesamt stellt diese Untersuchung eine Verbesserung der 
technischen Möglichkeiten zur Untersuchung der vaskulären Leberregeneration nach 
Leberresektion dar. 
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1 Summary 
Liver regeneration consists of parenchymal regeneration and also vascular growth. 
Due to technical limitation in quantifying vascular regeneration, more efforts were 
spent on studying parenchymal liver regeneration rather than vascular regeneration. 
However, vascular liver regeneration is as important as parenchymal liver 
regeneration. Thus, this study aims for improving techniques for quantifying hepatic 
vascular regeneration in mice. We defined four goals: to adapt an intraoperative 
monitoring procedure for determining  hepatic hemodynamics to be used for mice, to  
develop a workflow consisting of injecting a contrasting compound, micro-CT imaging 
of the explanted liver visualization of the vascular tree, to establish a  computational 
technique for assessing vascular regeneration based on vascular geometry,  and to 
investigate the effect of modulating the CXCR4-CXCR7-SDF-1 axis on hepatic 
vascular and parenchymal regeneration.  
First, we established a delicate monitoring procedure suitable for mice in order to 
measure hepatic hemodynamic parameters. Blood flow of portal vein and hepatic 
artery and portal venous pressure (PVP) were measured in normal mice as well as 
during the procedure of 70% PH and in liver lobe clamping experiments. The results 
indicated that this monitoring procedure was sensitive and suitable for detecting small 
changes in portal pressure and portal flow rate. 
Second, we wanted to assess hepatic vascular growth during regeneration after 
70%PH. Contrasting silicone compound injection prior to micro-CT scanning was 
used for visualization of hepatic vasculature. We adapted the silicone injection 
method for visualizing both hepatic vascular systems in mice. The biggest challenge 
for modifying this procedure was the determination of the adequate perfusion rate for 
the silicone compound. Based on the hepatic hemodynamic parameters acquired by 
the monitoring technique, we defined the perfusion rate for the silicone compound, 
0.2 ml/min. Maximal vessel length and radius of right inferior portal vein and hepatic 
vein were measured after digitalizing and visualizing the hepatic vascular trees based 
on µCT data in Imalytics Preclinical software.  
Third, based on this imaging workflow we developed a method to quantify hepatic 
parenchymal regeneration and vascular growth after 70%PH to investigate the 
underlying growth pattern. µCT data were converted into 3D vascular and territory 
reconstructions using HepaVision software. Total hepatic volume indicative of 
parenchymal regeneration was determined. Total hepatic volume and liver weight 
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were highly correlated, indicating that the increase of hepatic volume could be utilized 
as basis for the subsequent quantitative analysis of hepatic parenchymal 
regeneration. Then, cumulative vascular regenerative parameters, total edge length 
and total vascular volume, were computed based on vascular geometry. At last, 
parameters describing the vascular density, total edge length/ hepatic volume and 
the vascular volume fraction, were determined. We created a virtual resection model 
in HepaVision in order to eliminate the effect of portal hypertension induced by the 
extended hepatectomy. We compared parameters obtained after virtual resection 
and on POD 7 for exploring the growth pattern of liver regeneration after 70%PH. 
Despite the seemingly homogeneous 3D-growth, the observed vascular parameters 
were not compatible with the hypothesis of isotropic expansion of liver parenchyma 
and vascular structures. 
Forth, we applied the newly established work flow consisting of contrasting the 
specimen, image acquisition and data analysis to quantify the vascular regeneration 
after modulating the CXCR4 signaling pathway. Liver regeneration was not affected 
by administrating AMD3100, a CXCR4 antagonist. However, liver parenchymal 
regeneration (recovery of liver body weight ratio) and vascular growth (circumscribed 
vascular parameters) was impaired by applying TC14012, acting as both CXCR4 
antagonist and CXCR7 agonist, pointing to the relevance of this pathway for liver 
regeneration. 
In conclusion, we explored vascular liver regeneration in a meso- and macroscopic 
scale. We started by adapting  two delicate surgical tools, hepatic hemodynamic 
monitoring technique and intravascular silicone injection technique, for accessing the 
immediate  effects of partial hepatectomy and for studying the vascular growth during 
the first week post-PH. Next, we reported hepatic hemodynamic parameters and 
vascular regenerative parameters which can be utilized as the basis for exploring 
vascular growth in normal and partially hepatectomized mice. Furthermore, we 
investigated the growth pattern of hepatic vascular trees for better understanding the 
relationship between parenchymal liver regeneration and vascular liver regeneration. 
Last but not least, using the circumscribed vascular parameters we quantified the 
delayed and reduced vascular growth after modulating the CXCR4-CXCR7-SDF-1 
axis in 70%PH mouse model.  
Altogether, this study provides technical tools to further and deeper explore and 
understand hepatic vascular regeneration after liver resection.
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2 Introduction 
2.1 Hepatic vascular regeneration  
The liver has the remarkable capacity to fully regenerate after major loss of 
parenchyma. Liver regeneration requires reconstitution of liver parenchyma and 
vascular structures. Once liver injury or loss of hepatic tissue occurs, not only 
hepatocytes but also non-parenchymal cells, i.e LSECs, biliary epithelial cells as well 
as stellate cells, are involved in programmed liver regeneration (DeLeve 2013). 
Replication of hepatic parenchymal and non-parenchymal cells leads to the increase 
of liver mass and growth of blood vessels.  
Vascular liver regeneration mainly includes the proliferation of LSECs and the 
liberation of angiogenic factors (growth factors, cytokines and chemokines). About 2 
decades ago, Jacquelyn Maher first hypothesized that LSECs contribute to liver 
regeneration (Schwier et al. 2013). Now, evidence is accumulating that angiogenesis, 
the formation of new microvasculature from preexisting blood vessels, is essential for 
liver regeneration to proceed to completion. Although LSECs are known to contribute 
to the angiogenesis that accompanies parenchymal regeneration, emerging data now 
suggest a more complex and multifaceted role for LSECs in liver regeneration 
through their effects on other hepatic cells (Ding et al. 2014, Ding et al. 2010).  
Therefore, studying regeneration of hepatic vasculature can facilitate the 
understanding of the pivotal role of vascular growth in liver regeneration. Assessing 
vascular parameters quantitatively can contribute to elucidate the underlying 
mechanism of vascular growth and serve as a basis to develop novel therapeutic 
strategies.  
Due to the lack of adequate methods, nowadays, most studies are mainly focused on 
parenchymal liver regeneration rather than vascular liver regeneration. However, 
hepatic vascular growth and remodeling seems to be crucial in the progression of 
hepatic regeneration. Thus, it is urgently needed to establish methods for visualizing 
and quantifying vascular growth. 
 
2.2 Hepatic hemodynamic parameters  
The hemodynamic consequence of partial hepatectomy is the trigger for the activity 
of hepatocytes and LSECs, and further directs liver regeneration in an explosive rate. 
The relationship of altered hepatic hemodynamics and the regulation of hepatocyte 
proliferation after liver resection have been studied extensively. A dramatic 
hemodynamic stimulus occurs at the time of surgical removal of liver lobes. Despite 
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the fact that LSECs enter into DNA synthesis between 72 and 96 h after PH, the 
increase in the fenestration diameter and porosity indicative of the changes in the 
sinusoidal structure are observed within 5 min after the operation (Kandilis et al. 
2010). The changes in portal blood flow serve as the initial trigger for the activation of 
a complex cascade of events leading to cellular proliferation.  
The technical procedure of measuring hepatic hemodynamic parameters for rats was 
reported before by our group (Huang et al. 2010). However, due to the small size, 
adaptation of this procedure to the mouse represented a technical challenge.  
Technical details of the challenging intraoperative monitoring procedure suitable for 
the mouse were rarely described. Thus, it was urgently needed to establish and 
disseminate a method for acquiring the hepatic hemodynamic parameters, including 
portal blood flow and portal vein pressure. So, as a first step, we aimed at 
establishing a delicate procedure for monitoring the changes of hepatic 
hemodynamics in normal mice and in mice subjected to 70%PH.  
 
2.3 Visualization of vascular regeneration 
In parallel to the development of imaging techniques, several approaches for 
visualizing vascular growth on the lobule or organ scale in different organ vascular 
systems became available (Upputuri et al. 2015). The two main methods for 
contrasting the vascular tree prior to ex-vivo imaging are the vascular corrosion 
casting and silicone contrast compound injection technique. Both techniques allow 
subsequent µCT scanning to visualize hepatic vasculature and principally also the 
quantification of vascular and parenchymal parameters with the help of computational 
techniques. However, visualization of hepatic vasculature based on corrosion cast 
needs the digestion of liver parenchyma. In contrast, silicone injected specimen 
enables the subsequent histological work up including serial sectioning and 
histological analysis. Injection of the contrast compound allows imaging of the whole 
organ, the prerequisite for visualization and 3D reconstruction of hepatic parenchyma 
as well as vasculature. In contrast, corrosion casting only allows visualization of the 
injected vascular trees.  
Silicone contrast compound injection together with micro-CT (µCT) imaging 
technique can serve to characterize and describe the changes of vascular 
parameters under different circumstances associated with vascular regeneration. 
Silicone compound can be used to fill and opacify microvessels as well as large 
vessels prior to explanting the organ for ex-vivo imaging. Following injection, microfil 
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compound has to cure to form a three-dimensional cast of the vasculature. The 3D 
vascular trees can be visualized and subsequent vascular regenerative parameters 
can be quantified. This technique has been successfully used for assessing the 
vasculature in multiple organs(Ghanavati et al. 2014, Ehling et al. 2014b, Jing et al. 
2012) and in tumors (Downey et al. 2012, Ehling et al. 2014a).  
Typically, silicone compound is perfused systematically via the left ventricle instead 
of direct injection into the vascular system of interest. However, given the fact that the 
hepatic vascular system consists of two vascular trees, it is difficult to ensure equal 
homogenous perfusion of both trees after systemic perfusion with a highly viscous 
solution. Thus, we wanted to modify the silicone injection procedure making it 
suitable for visualizing portal vein and hepatic vein separately.  
 
2.4 Quantification of vascular regeneration  
Micro-CT data acquired from contrasted specimen can facilitate not only visualizing 
but also quantifying the vascular growth. Quantifying vascular growth requires 
quantifying changes in parameters appropriate for describing the geometry of 
vascular systems. Such parameters include vessel diameter/ thickness (Ehling et al. 
2014b, Ehling et al. 2014a), vessel length (Mittal et al. 2005, Wan et al. 2002), vessel 
volume (Langheinrich und Ritman 2006, Downey et al. 2012), vessel density (Bolland 
et al. 2008, Gayetskyy et al. 2014), branching angles (Parker et al. 1997), vessel 
number (Ghanavati et al. 2014, Downey et al. 2012), and vessel cross-section area 
(Huang et al. 1996). Parameters can be determined for individual vessel segments or 
as cumulative quantities. However, there is no widely accepted standard yet to 
describe vascular geometries. Thus, we wanted to quantify hepatic vascular 
regenerative parameters during the liver regeneration process. We also wanted to 
study the relationship between parenchymal regeneration and vascular regeneration 
by quantifying vascular density. Doing so, we wanted to explore the underlying 
growth pattern by comparing the observed to the expected growth pattern with 
isotropic expansion.  
 
2.5 The role of CXCR4-CXCR7-SDF-1α pathway in liver regeneration  
Once established, we wanted to demonstrate the added value of assessing hepatic 
vascular growth in a pilot study exploring the role of CXCR4-CXCR7-SDF-1α 
pathway.  
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Stromal-derived factor-1 alpha (SDF-1α, also known as CXCL12) binds to G-protein-
coupled CXCR4 and CXCR7. This chemokine plays an important and unique role in 
vasculogenesis and angiogenesis (Liekens et al. 2010) as well as in the regulation of 
stem/progenitor cell trafﬁcking (Rosenkilde et al. 2004).  
Within the liver, SDF-1α/CXCL12 is mainly produced by cholangiocytes and hepatic 
progenitor cells (Tsuchiya et al. 2012), biliary epithelial cells, hepatic stellate cells and 
LSECs (Hu et al. 2014). CXCL12 is upregulated in response to injury to initiate 
regeneration by switching on its receptors CXCR4 and CXCR7. It was reported that 
the expression levels of CXCR4 and CXCL12 increased after liver injury (Wilson et al. 
2015, Jiang et al. 2012). Thus, we hypothesized that CXCR4- SDF-1α pathway is 
involved in liver regeneration. We wanted to explore the role of this axis in liver 
regeneration especially for hepatic vascular regeneration in the mouse 70%PH-
model.  As a first step in this pilot experiment, we selected CXCR4 antagonist, 
AMD3100, which can block CXCR4 and subsequently interfere with cell proliferation 
as indicated in Figure 1 from (Faber et al. 2007) below. We hypothesized that, liver 
regeneration will be impaired by administration of AMD3100. 
 
Figure 1 in (Faber et al. 2007) 
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 Figure 1 in (Duda et al. 2011) 
 
 
However, as indicated in the Figure 1 from Duda (Duda et al. 2011), SDF-1α has 
interactions not only with CXCR4 but also with CXCR7. Thus, next, we selected the 
CXCR4 antagonist and CXCR7 agonist, TC14012, for blockade of CXCR4 and 
activation of CXCR7. In this way, TC14012 may activate the β-arrestin pathway via 
activation of GRK, leading to internalization of CXCR4 and scavenging of CXCL12. 
Inhibiting the role of CXCL12 might impair tissue regeneration after injury. Thus, we 
hypothesized that liver regeneration will be impaired by giving TC14012. 
The results obtained from this pilot experiment can serve as the basis for a thorough 
investigation of this pathway in the future. 
 
 
2.6 Experimental design and aims 
2.6.1 Establish a  method to determine hepatic hemodynamics in mice 
A reliable technique to monitor hepatic hemodynamics in mice is needed. 
Establishment of the monitoring procedure was achieved in three steps (see Table 1) 
using normal mice (step 1) and mice subjected to selective clamping (Step 2) and to 
liver resection (Step 3).   
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Table 1. Group distribution for monitoring hepatic hemodynamics in mice 
 Objective of each step in monitoring study Animal numbers 
Step 1 Establish monitoring procedure and acquire normal 
values of hepatic parameters 
N=10 
Step 2 Measure hepatic hemodynamic parameters in 
clamping/ declamping liver lobe experiment for 
detecting small changes using monitoring technique  
N=5 
Step 3 Measure hepatic hemodynamic parameters before 
and immediately after 70%PH 
N=25 
 
2.6.2 Establish a method to visualize vascular regeneration 
Vascular liver regeneration is as important as parenchymal liver regeneration. 
However, the kinetics of vascular growth during the process of liver regeneration is 
not well described yet.  
Thus, the goal of this step was to observe the time course of hepatic vascular 
regeneration in 70%PH mouse model (Table 2). In order to achieve this goal, a 
method suitable for visualizing hepatic vasculature is needed. Contrasting the 
vascular trees using silicone injection was chosen for this purpose. This technique 
also has the potential benefit resulting from a detailed analysis of the specimen using 
µCT and the subsequent detailed histological workup of the same specimen using 
serial sections for analyzing vascular liver regeneration. This silicone injection 
technique was demonstrated in detail in Manuscript II. 
 
 
Table 2. Group distribution for visualizing hepatic vascular regeneration in mice 
Group 
Animal numbers Success 
rate Unsuccessful cases successful cases 
Portal venous system N=10 N=12 55% 
Hepatic venous system N=3 N=24 89% 
 
2.6.3 Establish a method to quantify vascular regeneration 
After achieving the visualization of vascular growth, we further wanted to study 
hepatic vascular regeneration in a qualitative and quantitative way. Traditionally, 
quantification of liver regeneration usually includes determination of cell proliferation 
rates and liver weight recovery, but not the assessment of vascular growth.  
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This study aimed at (1) quantitatively describing parenchymal and vascular 
regeneration, and (2) determining their relationship. Both together are needed to (3) 
characterize the underlying growth pattern. The changes of these regenerative 
parameters (as listed in the Table 3) after 7 days’ regeneration were described and 
elucidated in Manuscript III. 
 
Table 3. Parameters computed to describe hepatic regeneration and vascular growth  
Parameters Unit Explanation Software  
Total hepatic volume  ml  Volume of total liver or RIL HepaVision 
In/Outflow vascular 
radius 
mm Radius of entry point to RIL Imalytics 
Maximal vessel length mm Intravascular distance from root 
to most distant tip 
Imalytics 
Total edge length mm Sum of lengths of all edges in 
vascular tree 
ATA 
Total vascular volume ml Sum of volumes of all edges in 
vascular tree 
ATA 
Total edge length/ 
hepatic volume 
mm/ml Vascular length per liver volume  (derived 
parameter) 
Vascular volume fraction  
 
ml/ml Vascular volume per liver 
volume 
(derived 
parameter) 
(ATA is the automatic tree analysis using the tools from (Schwen und Preusser 2012). 
 
2.6.4 Explore the role of CXCR4-CXCR7-SDF-1α pathway in liver regeneration 
In this first preliminary experiment we wanted to assess the value of quantifying 
hepatic vascular growth. We aimed at interfering with liver regeneration especially 
with hepatic vascular regeneration after 70%PH in mice by modulating CXCR4-
CXCR7-SDF-1 pathway using AMD3100 and TC14012, CXCR4 antagonist and 
CXCR4 antagonist+CXCR7 agonist respectively (Table 4).  
We determined body weight recovery and liver enzymes as indicator for the overall 
surgical stress and damage to the liver, liver weight recovery and total BrdU 
proliferation index to assess parenchymal regeneration and the selective parameter 
maximal vessel length and inflow vascular radius of right inferior portal vein to 
quantify vascular growth.                                                                          
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Table 4. Interfering with liver regeneration by modulating CXCR4-CXCR7-SDF-1 axis 
Post-operative 
day(POD) 
                 Group  
Naïve Sham 
op 
AMD3100 exp. TC14012 exp. 
70%PH
+PBS 
70%PH 
+AMD3100 
70%PH 70%PH+
TC14012 
0 N=6      
POD2  N=6 N=6 N=6 N=6 N=4 
POD3  N=6 N=6 N=6 N=6 N=4 
POD7  N=6 N=6 N=6 N=6 N=4 
 
Table 5. Silicone injection after modulating CXCR4-CXCR7-SDF-1 axis by TC14012 
in 70%PH mouse model 
Post-operative day (POD) 70%PH 70%PH+TC14012 
POD 2 N=3 N=3 
POD 7 N=3 N=3 
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3 MANUSCRIPT  
3.1 Manuscript I 
 
Monitoring of Systemic and Hepatic Hemodynamic Parameters 
 in mice 
 
Chichi Xie, Weiwei Wei, Tao Zhang, Olaf Dirsch, Uta Dahmen 
 
J. Vis. Exp. e51955, doi:10.3791/51955 (2014). 
The video component of this article can be found at 
http://www.jove.com/video/51955/ 
 
Authorship 
First author 
 
Authors’ contributions 
 
Chichi Xie: Established microsurgicall procedure, cutting and editing the film, 
analyzing the results and writing of the manuscript.  
Weiwei Wei: Assisting in microsurgical procedure development 
Tao Zhang: Involved in establishing the microsurgical procedure 
Olaf Dirsch: Guidance and supervision of the project 
Uta Dahmen: Supervising the project 
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Summary 
In this study, we demonstrated a real-time monitoring procedure, for acquiring 
systemic and hepatic hemodynamic parameters suitable for mice. This monitoring 
procedure is useful in experimental research in mice that require obtaining systemic 
and hepatic hemodynamic parameters related with vascular liver regeneration. We 
applied this procedure to monitor the changes of hepatic hemodynamic parameters, 
including portal blood flow and portal venous pressure, before and immediately after 
70% partial hepatectomy and during clamping and declamping experiment in mice. In 
conclusion, this monitoring procedure is sensitive to detect small changes of vascular 
perfusion. 
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3.2 Manuscript II 
 
Visualization of vascular and parenchymal regeneration 
after 70% partial hepatectomy in normal mice 
 
 
 
Chichi Xie, Weiwei Wei, Andrea Schenk, Lars Ole Schwen, Sara 
Zafarnia, Michael Schwier, Felix Gremse, Isabel Jank, Olaf Dirsch, 
Uta Dahmen 
 
 
The Journal of Visualized Experiments - Accepted 
 
J. Vis. Exp. e53935, doi:10.3791/53935 (2016) 
 
 
Authorship 
 
First author 
 
 
Authors’ contributions 
 
Chichi Xie: established microsurgical procedure, cutting and editing the film, 
analyzing the results and writing of the manuscript.  
Weiwei Wei: assisting in microsurgical procedure development, revising manuscript  
Andrea Schenk:  providing 3D vascular and territories reconstructions and 
manuscript revising 
Lars Ole Schwen: computing vessel parameters and manuscript revising 
Sara Zafarnia: micro-CT scanning of microfil samples 
Michael Schwier: providing 3D vascular reconstructions based on serial sections  
Felix Gremse: providing Imalytics Preclinical software and manuscript revising 
Isabel Jank: audio recording and manuscript revising 
Olaf Dirsch: Guided and supervised the project 
Uta Dahmen: Supervising the project and manuscript revising  
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Summary 
 
In this study, we established and demonstrated the delicate silicone injection 
technique required to achieve optimal contrasting both vascular systems (portal vein 
and hepatic vein) and showed the potential benefit resulting from a detailed analysis 
of the resulting specimen using µCT and histological serial sections for subsequent 
analysing vascular liver regeneration. The vascular growth at each postoperative day 
was visualized and vascular regenerative parameters, such as maximal vessel length 
and radius, were obtained enabling for further analysis. In conclusion, this technique 
has the potential to be extensively applied to studies concerning vascular anatomy 
and growth in various animal and disease models. 
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SHORT ABSTRACT:  
Tools used for visualizing vascular regeneration require methods for contrasting the 
vascular trees. This film demonstrated a delicate injection technique used to achieve 
optimal contrasting of the vascular trees and illustrate the potential benefits resulting 
from a detailed analysis of the resulting specimen using µCT and histological serial 
sections. 
 
LONG ABSTRACT:  
A modified silicone injection procedure was used for visualization of the hepatic 
vascular tree. This procedure consisted of in-vivo injection of the silicone compound, 
via a 26G catheter, into the portal or hepatic vein. After silicone injection, organs 
were explanted and prepared for ex-vivo micro-CT (µCT) scanning. The silicone 
injection procedure is technically challenging. Achieving a successful outcome 
requires extensive microsurgical experience from the surgeon. One of the challenges 
of this procedure involves determining the adequate perfusion rate for the silicone 
compound.  The perfusion rate for the silicone compound needs to be defined based 
on the hemodynamic of the vascular system of interest. Inappropriate perfusion rate 
can lead to an incomplete perfusion, artificial dilation and rupturing of vascular trees.  
The 3D reconstruction of the vascular system was based on CT scans and was 
achieved using preclinical software such as HepaVision. The quality of the 
reconstructed vascular tree was directly related to the quality of silicone perfusion. 
Subsequently computed vascular parameters indicative of vascular growth, such as 
total vascular volume, were calculated based on the vascular reconstructions. 
Contrasting the vascular tree with silicone allowed for subsequent histological work-
up of the specimen after µCT scanning. The specimen can be subjected to serial 
sectioning, histological analysis and whole slide scanning, and thereafter to 3D 
reconstruction of the vascular trees based on histological images. This is the 
prerequisite for the detection of molecular events and their distribution with respect to 
the vascular tree. This modified silicone injection procedure can also be used to 
visualize and reconstruct the vascular systems of other organs. This technique has 
the potential to be extensively applied to studies concerning vascular anatomy and 
growth in various animal and disease models.  
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INTRODUCTION:  
Liver regeneration is often determined by measuring the increase of liver weight and 
volume and by assessing the hepatocyte proliferation rate16. However, liver 
regeneration is not only inducing parenchymal regeneration but also vascular 
regeneration6. Therefore, vascular growth should be further investigated with respect 
to its role in the progression of liver regeneration. Visualization of the hepatic 
vascular system is critical to advancing our understanding of vascular regeneration.  
Numerous indirect methods have been developed to study the underlying molecular 
mechanisms of hepatic vascular regeneration. Traditionally, detection of cytokines 
(vascular endothelial growth factor, VEGF)14, chemokines and their receptors 
(CXCR4/CXCR7/CXCL12)4 have been the mainstay for studying vascular 
regeneration. However, a 3D model together with quantitative analysis of the 
vasculature would add critical anatomic information to gain a better understanding of 
the important relationship between hepatic parenchymal and vascular regeneration. 
To visualize the hepatic vascular system, which requires contrasting the vascular 
trees, mice were injected with a radiopaque silicone rubber contrast agent directly 
into the portal or hepatic venous vascular tree.  After polymerization of the silicone 
and explantation of the organ, the liver samples were subjected to µCT scanning 
using a CT scanner. The scans resulted in voxel image representations of the 
silicone-injection specimens9.  
For quality control, the vascular system was first visualized in 3D using preclinical 
software. Segmentation was performed by setting a threshold between the soft tissue 
intensity and the vessel intensity. The resulting vessel mask was visualized using 
surface rendering. The software also allowed for manual determination of two 
parameters of vascular growth: maximal vessel length and radius.  
A preclinical software was then used for 3D reconstruction of vascular trees and 
subsequent calculation of the supplying or draining vascular territories13. In addition, 
this software automatically determined certain parameters of vascular growth, such 
as the total length of all visible vascular structures also known as the total edge 
length or total vessel volume.   
The silicone perfusion procedure was performed in naive mice and in mice that 
underwent 70% partial hepatectomy (PH). Livers were collected at different 
                                             MANUSCRIPT II 28 
 
observation time points after resection for analyzing vascular and parenchymal liver 
regeneration using the aforementioned visualization and quantification technique. 
The main goals of this film are to: (1) demonstrate the delicate injection-technique 
required to achieve optimal contrasting and (2) show the potential benefit resulting 
from a detailed analysis of the resulting specimen using µCT and histological serial 
sections. After watching this film, the reader should have a better understanding of 
how to inject silicone compound into a specific vascular system and of the usefulness 
and applicability of the technique. 
PROTOCOL:  
Procedures involving animal subjects have been approved by Thüringer Landesamt 
für Verbraucherschutz Abteilung Tiergesundheit und Tierschutz, Germany. Because 
the portal venous system was visualized separately from the hepatic venous system, 
separate animals were needed for the different vascular trees. 
 
1. Reagents preparation. 
1.1 Heparin-saline solution 
1.1.1  Add 0.1 ml heparin into 10 ml saline (5 IU/ml). 
1.2  Silicone compound mixture 
1.2.1 Add 2 ml MV-120 in one 5 ml tube. Dilute MV-120 by adding 3 ml MV diluent 
resulting in a 40% solution. 
 
2 Portal venous system silicone injection. 
2.1 Laparotomy. 
2.1.1 Place the mouse in the anesthesia induction chamber and anaesthetize it with 
2% isoflurane and 0.3 ml/min oxygen.  
2.1.2 Fix the anaesthetized mouse on the operating table using tape with continuous 
inhalation of 2% isoflurane and 0.3 ml/min oxygen. Check the toe-pinch withdrawal 
reflex of the mouse and start operation if the reflex is absent.  
2.1.3 Make a transverse incision on the abdomen using scissors for the skin layer 
and an electric coagulator for the muscle layer. Move out the intestines to the left side 
using cotton tips and cover the intestines with saline soaked gauze. 
2.2 Catheter insertion. 
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2.2.1 Dissect portal vein under the microscope using micro-forceps. Place one 6-0 
silk suture underneath  the extrahepatic portal vein, in approximately 1 mm distance 
to its bifurcation and tie it loosely for later use. 
2.2.2 Inject prepared heparin-saline solution via penile vein (male) or inferior vena 
cava (female) for systemic heparinization for 5min.  
2.2.3 Insert the 26-gauge (26G) catheter with needle into portal vein and fix it with a 
clamp 
2.3 Heparin-saline solution and silicone compound perfusion 
2.3.1 Load heparin-saline solution in 5 ml syringe and turn on perfusion device. Fill 
the catheter fully with heparin-saline solution to avoid air bubbles. 
2.3.2 Connect extension tube to the catheter and fix them tightly. Start heparin-
saline perfusion with a perfusion rate of 0.4 ml/min. 
2.3.3 Ligate pre-placed 6-0 silk suture for double fixing the catheter and blocking 
blood flow from splenic vein and mesenteric vein. Euthanatize the mouse by 
exsanguination via perfusion under anesthesia.  
2.3.4 Rinse the liver using saline during the whole perfusion procedure in order to 
keep it moist. 
2.3.5 Add 0.1 ml curing agent into the MV-120 tube. Change heparin-saline syringe 
to silicone syringe.  
2.3.6 Start silicone perfusion with a perfusion rate of 0.2 ml/min for approximately 1 
minute to prefill the catheter system and to fill the portal vein system. . Stop silicone 
perfusion when the vessels on the surface turn blue. 
2.4 Sampling  
2.4.1 Keep the liver in-situ until the silicone is fully polymerized after approximately 
15 to 30 min. Dissect ligaments connecting liver and adjacent organs with care to 
keep liver intact. Explant the liver and put it into formalin for fixation. 
 
3 Hepatic venous system silicone injection. 
3.1 Perform laparotomy as performed in step 2.1 and expose operative field fully.  
3.2 Catheter insertion. 
3.2.1 Dissect portal vein under the microscope using micro-forceps. Place one 6-0 
silk suture underneath  the extrahepatic portal vein, in approximately 1 mm distance 
to its bifurcation and tie it loosely for later use. 
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3.2.2 Inject prepared heparin-saline solution via penile vein (male) or inferior vena 
cava (female) for systemic heparinization for 5min. 
3.2.3 Insert one 26G catheter (catheter 1) with needle into portal vein and fix it with 
a clamp. Insert another 26G catheter (catheter 2) with needle into inferior vena cava 
and fix it with a clamp. 
3.2.4 Ligate the branches of inferior vena cava (including left and right renal veins) 
and its distal end using 6-0 synthetic, monofilament, non-absorbable polypropylene 
suture. 
3.3  Heparin-saline solution and silicone compound perfusion 
3.3.1 Load heparin-saline solution in 5 ml syringe and turn on perfusion device. Fill 
catheter 1 completely with heparin-saline solution to avoid air bubbles. Connect 
extension tube to catheter 1 and fix it tightly. Start heparin-saline perfusion at a rate 
of 0.4 ml/min. 
3.3.2 Ligate pre-placed 6-0 silk suture for double fixing the catheter and blocking 
blood flow from splenic vein and mesenteric vein. Euthanatize the mouse by 
exsanguination via perfusion under anesthesia. 
3.3.3 Rinse the liver using saline during the whole perfusion procedure in order to 
keep it moist. Add 0.1 ml curing agent into the MV-120 tube. Exchange heparin-
saline syringe with silicone syringe.  
3.3.4 Place a clamp on the suprahepatic inferior vena cava to obstruct the outflow of 
the liver. 
3.3.5 Connect the extension tube to catheter 2 and start silicone perfusion with a 
perfusion rate of 0.2 ml/min for approximately 2 minutes to reach an objective hepatic 
vascular volume as reported. Stop silicone perfusion when the vessels on the surface 
turn blue. 
3.4  Sampling:  
3.4.1 Dissect hepatic ligaments avoiding any injury to the liver. Explant the liver and 
put it into formalin for fixation. 
 
4 Micro-CT (µCT) scanning  
To scan the explanted liver sample using µCT, the following steps are needed. 
4.1  Take the liver sample out of the fixation solution.  Place the liver onto the µCT 
bed. Put the µCT bed with the liver sample into the µCT.  
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4.2 Acquire topogram before starting the scan. Use one subscan for the small liver 
sample and two subscans for large samples. 
4.3 Select a µCT protocol with a high resolution (e.g., HQD-6565-390-90). This 
protocol acquires 720 projections with 1032 x 1012 pixels during one full rotation with 
the scanning time of 90 s per sub-scan. Start the µCT scan. 
 
5 Histological serial sections 
5.1 Embed the liver specimen in paraffin as a whole after µCT scanning. Cut 
whole paraffin sample into 4 µm sections, resulting in a series of 2000 to 2500 
sections. 
5.2  Stain sections with appropriate staining technique to visualize molecular 
events of interest such as Ki-67 as proliferation marker and HMGB1 as a marker of 
ischemic damage. Determine sequence of staining in respect to scientific question.  
5.3 Use a whole slide scanner to digitalize the stained sections. 
5.4 Perform 3D-reconstruction of vascular tree(s) (already feasible) and visualize 
3D-distribution of molecular events in respect to vascular tree (research in progress). 
 
REPRESENTATIVE RESULTS: 
Quality criteria:  
The quality of silicone injection can be judged with the naked eye during the 
procedure. The small vessels on liver surface fill gradually with the blue compound. If 
the normal vascular structure was observed on the liver surface, the silicone rubber 
injection quality was good. If the perfusion volume was insufficient, the small vessels 
on the liver surface were not fully filled. In contrast, over filling caused vascular 
rupture as indicated by irregular blue spots on the surface of the organ. Both are 
causing difficulties upon 3D-reconstruction ultimately rendering a procedure a failure. 
For better evaluation of the injection quality, µCT scanning followed by 3D vascular 
reconstruction using preclinical software was performed. Injection was determined to 
be successful when segmentation resulted in the visualization of an intact complete 
vascular tree without ruptured structures indicated by visible extravasation. If the 
vascular tree appeared incomplete (Fig. 1A), perfusion volume was insufficient. If 
more than one vascular tree appeared or extravasation was seen (Fig. 1B), perfusion 
volume or pressure was inadequate. This was the most likely reason for a failure. 
Perfusion pressure can theoretically vary slightly depending on the viscosity of the 
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solution.  Viscosity is dependent on the polymerization time elapsed between mixing 
the compound and injection into the vascular system. Since some manipulation is 
required for mixing and injection, time interval can slightly vary between 3 min to 5 
min. 
If the solution is of low viscosity, perfusion pressure is low. In this case the compound 
can transfer into the non-injected vascular tree via the sinusoidal system leading to a 
slightly higher perfusion volume. If the solution is further polymerized leading to a 
higher viscosity, the perfusion pressure will rise, causing disruption of the vessels 
and extravasation. 
Determination of objective perfusion volume 
Since inadequate perfusion or hyperperfusion would cause failure of injection, 
standardizing the perfusion volume was considered. As reported2, 6% of the hepatic 
volume is occupied by blood and 44% of the blood in the liver resides in the large 
vessels (e.g., hepatic artery, portal vein). Liver volume in mice is about 1.3 ml11. 
Therefore, total vascular volume in portal venous system in normal mice was 
estimated to range between 0.03 ml and 0.04 ml. Flow rate was set to 0.2 ml/min and 
total perfusion time was set to approximately 1 minute resulting in a total injected 
volume of around 0.2 ml.  
This seemingly high volume is needed, since the catheter system must be prefilled, 
which takes about 0.1-0.15 ml. An extra volume of 0.05 ml is needed to fill the 
proximal portal vein between liver hilum and the ligation of the catheter. Flow rate for 
hepatic vein injection was also set to 0.2 ml/min but total perfusion time was 
prolonged to 2 min, resulting in a higher total volume of about 0.4 ml. Total 
intrahepatic vascular volume was assumed to be similar to the total portal vein 
vascular volume. However, the volume needed to fill the intrahepatic vena cava 
between the infrahepatic ligation and the suprahepatic clamp was estimated with 0.2 
ml. 
Success rate:  
A total of 49 animals were subjected to silicone injection: 22 animals into the PV 
system and 27 animals into the HV system. Our success rate of injection was 55% 
(12/22) in the PV group and 89% (24/27) in the HV group. Taking into account that 
the PV group was used to establish the silicone injection technique in the beginning 
(n=4), the success rate of injection for the PV system should effectively be higher 
than 55%. However, µCT images obtained from these injections were suitable for 3D 
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reconstruction and quantitative analysis. Additionally, the vascular trees from either 
PV or HV of 36 mice could be reconstructed with the Imalytics Preclinical software.  
Parenchymal and vascular regeneration:  
A time resolved µCT series of murine liver samples after hepatectomy was subjected 
to a qualitative analysis. Parenchymal regeneration consisted of 3D growth of the 
remnant liver. Vascular regeneration was defined as tissue that displayed an 
increase in the length and diameter of the vascular stem, with its main branches and 
outgrowth of additional terminal branches, in both the portal venous and hepatic 
venous tree.  
Currently, several quantitative parameters suitable for describing vascular growth and 
the relationship between hepatic parenchymal regeneration and vascular 
regeneration are under investigation. These include parameters indicative of vascular 
growth, including maximal vascular length (Fig. 2), vascular radius and vascular 
density in terms of total vascular length/liver volume or vascular volume/liver volume. 
Total liver volume and volume of selected liver lobes were calculated. In normal livers, 
total liver volume ranged from 1.2 ml to 1.6 ml (n=6, including both the PV group and 
HV group). It decreased to 0.6 to 0.7 ml after performing an extended liver resection 
by removing the left lateral and median lobe. The liver volume increased continuously 
during the liver growth. By post-operative day 7 (POD 7), the liver volume increased 
to approximately 88% of its original volume, i.e., by 2.6-fold. The increase of liver 
volume correlated with liver weight recovery. 
Total vascular volumes of the PV system and HV system were computed. Total 
vascular volume of the HV system was higher than in PV system, because part of the 
intrahepatic inferior vena cava was included. Total vascular volume of PV system 
ranged from 0.05 to 0.08 ml in normal mice. It decreased to 0.03 to 0.04 ml after 70% 
partial hepatectomy. By POD 7, total vascular volume of the remnant liver increased 
to 100% of original volume. Total vascular volume of HV ranged from 0.14 to 0.16 ml. 
Vascular volume decreased to 0.08 to 0.09 ml after resection. Within the first 
postoperative week, the total vascular volume of the remnant liver increased by 94% 
of original value.  
As the relation between results, increase in vascular volume and parenchymal 
volume, a vascular density was calculated, more precisely the vascular volume 
fraction (vascular volume divided by liver volume). This revealed that vascular 
volume fraction remained relatively stable throughout the regeneration process.  
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3D visualization of molecular events:  
After CT-scanning the selected specimens were subjected to serial sectioning, 
yielding to up to 2000 slides, which were fully digitalized and used to reconstruct the 
portal as well as the hepatic venous tree12. This is the prerequisite for the future 3D 
visualization of molecular events during regeneration in respect to the growing 
vascular tree.  
 
FIGURE LEGEND:  
 
Figure 1. Monitoring the quality of silicone injection 
 
A. Incomplete filling of right inferior portal vein (arrow in the left) and caudate portal 
vein (arrow in the right) were visualized in Imalytics Preclinical software as 
discontinuities of the vascular tree. This indicated an inadequate perfusion pressure 
or perfusion volume or the existence of air bubbles. B. Extravasation of right inferior 
portal vein was visualized which indicated disruption of a vessel due to inadequate 
pressure or hyperperfusion. 
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Figure 2. Measurement of maximal vessel length of right inferior portal vein 
 
To determine the maximal vessel length, one start point and one end point were 
placed at the root and distal end of the right inferior portal vein (RIPV) of the vascular 
mask (blue and magenta ball markers) in preclinical software. The vascular path 
length of the RIPV (10.95 mm) was obtained as part of evaluating the “Path 
Tortuosity”. 
 
 
DISCUSSION:  
Contrasting the vascular tree by silicone injection and µCT scanning has been 
introduced in tumor models and neurological disease models frequently to study the 
angiogenic progression5,7,8,10. Improvements in methodology of silicone injection 
were made in the present study for visualizing and quantifying vascular growth after 
partial hepatectomy in mice. 
There are a number of critical steps needing attention to achieve good perfusion 
quality. First of all, systemic heparinization is highly recommended before flushing the 
liver with heparin or saline to avoid blood clotting inside the liver. Elimination of air 
bubbles from the tubing is also important to achieve good quality of silicone perfusion. 
The determination of perfusion rate and pressure should first be based on 
physiological hemodynamic parameters17. Perfusion time reflects the total injected 
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volume and is estimated taking the expected intravascular volume and the prefilling 
volume of the catheter system into account.  
Silicone is a highly viscous compound which differs from blood or saline. Therefore, 
several trials are needed for adjusting perfusion rate and pressure. Maintaining 
constant injection flow rate and pressure is necessary to prevent severe dilation or 
even rupture of small vessels. Perfusion time is set according to the estimated 
needed injection volume. However, perfusion should be stopped immediately when 
the blue compound becomes visible in vessels on the surface of the liver. Otherwise, 
the silicone can drain into sinusoids and into another vascular system which will 
interfere with later reconstruction and analysis. 
Typically, silicone is perfused systematically via the left ventricle in most published 
reports 1,3,15. The left ventricle is easy to expose to enable free access to the injection 
site. However, the disadvantage is that this route is rather indirect because the 
contrast agent has to undergo circulation before reaching the site of interest. 
Therefore, the surgical procedure of silicone injection technique has been modified in 
this study. In contrast to the frequently selected indirect route of application 
performed by others, silicone compound was directly injected into the vascular 
system of interest, instead of contrasting the whole body. In this way, the velocity and 
volume of perfusion can be better controlled. The portal venous system and hepatic 
venous systems can be perfused and reconstructed separately for later individual 
analysis, as shown in the video. 
The limitation of this modified procedure is the technical difficulty. It is challenging to 
successfully perform an intraportal injection using highly viscous compound in mice, 
because the vascular structure is so delicate. It is rather easy to destroy the vessels 
during the procedure. Thus, portal vein dissection and catheter insertion should be 
performed gently. 
Contrasting of the vascular trees and subsequent µCT imaging of the explanted livers 
is a useful tool for visualizing and quantifying vascular regeneration after partial 
hepatectomy. Quantitative vascular parameters can be utilized for better 
understanding of the kinetic of vascular growth in the progression of liver 
regeneration. Furthermore, 3D reconstruction of both hepatic vascular systems 
based on serial sections is technically feasible, albeit representing an enormous work 
load. 
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This technique can be applied in multiple models where visualization and 
quantification of vascular growth is important. Moreover, 3D visualization of molecular 
events in respect to the underlying vascular tree is at reach. Examples of molecular 
events of interest could be the detection of proliferation marker such as Ki-67 or 
markers of ischemic damage such as HMGB1. Assessing the spatially resolved 
molecular events in the vicinity of the regenerating vascular tree within the 
regenerating hepatic parenchyma is the prerequisite for advanced multi-scale 
systems biology modeling. This silicone injection technique is one experimental step 
towards reaching this goal.  
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Summary 
In this study, we quantitatively described the increase of parenchymal and vascular 
growth during regeneration, quantified the relationship between regenerating 
parenchyma and vasculature and compare the observed growth to hypothetical 
isotropic expansion. Geometric parameters were selected and evaluated in the 
vascular data sets of normal and liver-resected mice. Determination of parameters 
different time points provided a quantitative description of vascular regeneration 
which was, in turn, compared to parenchymal volume recovery to explore the growth 
pattern. Prospectively, this quantification approach can be used for investigating 
hepatic vascular regeneration under different conditions. 
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Abstract 
Background Liver regeneration consists of cellular proliferation leading to 
parenchymal and vascular growth. Quantification of regeneration usually includes 
determination of cell proliferation rates and liver weight recovery, but not the 
assessment of vascular growth. This study aims at (1) quantitatively describing 
parenchymal and vascular regeneration, and (2) determining their relationship. Both 
together are needed to (3) characterize the underlying growth pattern. 
Method Specimens were created by injecting a polymerizing contrast agent in either 
portal or hepatic vein in normal or regenerating livers after 70% partial hepatectomy 
(PH). 3D image data were obtained through µCT scanning.  
Parenchymal growth was assessed by determining weight and volume of the 
regenerating liver. Vascular growth was described by manually determined 
circumscribed parameters (maximal vessel length and radius of right inferior 
portal/hepatic vein), automatically determined cumulative parameters (total edge 
length and total vascular volume), and parameters describing vascular density (total 
edge length/volume, vascular volume fraction).  
The growth pattern was explored by comparing the relative increase of these 
parameters to the increase expected in case of isotropic expansion. 
Results Liver volume recovery paralleled weight recovery and reached 90% of the 
original liver volume within 7 days (POD 7).  
Comparing radius-related vascular parameters immediately after surgical resection 
and after virtual resection in-silico revealed a slight increase, possibly reflecting the 
effect of resection-induced portal hyperperfusion. Comparing length-related 
parameters between POD 7 and after virtual resection showed similar vascular 
growth in PVs and HVs. In contrast, radius-related parameters increased slightly 
more in the PV-group. 
Despite the seemingly homogeneous 3D-growth, the observed vascular parameters 
were not compatible with the hypothesis of isotropic expansion of liver parenchyma 
and vascular structures. 
Conclusion We present an approach for the quantitative analysis of the vascular 
systems of regenerating mouse livers. Prospectively, this approach can be used to 
investigate hepatic vascular regeneration under different conditions. 
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Introduction  
Livers have the remarkable capability to fully regenerate after major loss of 
parenchyma. Regeneration requires reconstitution of liver parenchyma and vascular 
structures. Two major cell types involved in the regeneration at a microscopic scale 
are hepatocytes and liver sinusoidal endothelial cells (LSECs). Proliferation of these 
cells leads to the increase of liver mass and growth of blood vessels, respectively [1]. 
The present study focuses on these changes on a meso- and macroscopic scale. 
In the past, more efforts were spent on studying parenchymal liver regeneration 
rather than on vascular regeneration. Parenchymal growth is typically quantified on 
the cellular level by determining the hepatocyte proliferation index and on the lobule 
respectively organ level by measuring hepatic weight or volume, see [2] for a review.  
In particular, changes in geometry and shape of the hepatic lobes are typically not 
addressed. Inhomogeneous growth of the liver or of a given liver lobe may point to a 
disturbance in liver regeneration. Thus, we here investigated the growth pattern in 
liver regeneration. Based on macroscopic observations, one could assume that liver 
regeneration resembles isotropic expansion. Therefore we wanted to compare the 
changes in vascular and parenchymal parameters observed after seven days of 
regeneration to the ones expected in case of isotropic expansion. 
Growth and remodeling of liver vessels seems to be crucial in the process of hepatic 
regeneration. Vascular regeneration mainly consists of the prolongation of the main 
vessel branches and outgrowth of small terminal branches. Studying vascular 
regeneration can facilitate the understanding of the pivotal role of vascular growth for 
the process of regeneration. Traditionally, vascular growth is assessed on a cellular 
level indirectly by quantifying proliferation of LSECs with specific markers [3]. 
However, it is still hard to quantify vascular growth routinely and directly on the 
macroscopic level. 
As the development of imaging techniques, there are several approaches available 
for visualizing vascular growth [4] on the lobule or organ scale in different organ 
systems. Silicone injection in combination with micro-CT (µCT) imaging techniques 
are established and commonly used for assessing vascular growth. This contrasting 
technique has been used to successfully evaluate vasculature in organs (e.g., brain 
[5], liver [6] and bone [7;8]) and tumors [9;10]. This technique allows a more thorough 
structural characterization of vasculature than 2D images. Imaging also provides 
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quantitative data of vascular growth, which allows a mathematical description of the 
biological phenomenon of regeneration. Despite these promising advances for 
visualization and quantification of vascular regeneration, this technique was not well 
established for livers in small experimental animals. We previously adapted this 
technique to rodent livers [11]. It proved to be very helpful to identify anatomical 
variants. This study shows that the technique is also useful for quantifying 
regeneration. 
Quantifying vascular growth requires numerically evaluating the changes in 
parameters appropriate for describing the geometry of vascular systems. Such 
parameters include vessel diameter/ thickness [6-8], vessel length [12;13], vessel 
volume [9;14;15], angles at branchings [16], vessel number [10;17], and vessel 
cross-section area [18]. Parameters are determined for individual vessel segments or 
as cumulative quantities in the literature mentioned before. Additionally, the 
dependency on the hierarchy in vascular trees was considered [18-20]. However, 
there is no widely accepted standard yet to describe vascular geometries. 
The goals of the present study were to (1) quantitatively describe the increase of 
parenchymal and vascular growth during regeneration, and (2) to quantify the 
relationship between regenerating parenchyma and vasculature in order to (3) 
compare the observed growth to hypothetical isotropic expansion.  
For this purpose, 70% partial hepatectomy (PH) was performed in mice, specimens 
of the hepatic vasculature at different time points were created by injection of a 
radiopaque polymerizing agent, µCT imaging was performed, and geometric 
representations of the vasculature were obtained from the image data. Geometric 
parameters evaluated in the vascular data sets of normal and liver-resected mice. 
Determining parameters at different time points provided a quantitative description of 
vascular regeneration which was, in turn, compared to parenchymal volume recovery 
to explore the growth pattern. Furthermore, these changes in geometric parameters 
were compared to changes expected in case of isotropic expansion. This finally led to 
the conclusion that the observed regeneration did not resemble isotropic expansion. 
 
 
 
 
                                            MANUSCRIPT III 45 
 
Material and Methods  
Experimental Design - Workflow Overview 
The workflow of creating and scanning specimens of the livers (n=3 animals/ time 
point in the PV group or the HV group) as well as subsequent image analysis is 
illustrated in [Figure 1]. 
Experiments and Image Acquisition 
Animals 
Animal experiments were performed in male inbred C57BL/6N mice (25 g to 30 g, 8-
10 weeks, Charles River, Sulzfeld, Germany). Mice were fed a laboratory diet (Ssniff 
Spezialdiäten GmbH, Soest, Germany) with water and mouse chow ad libitum until 
surgery and were kept under constant environmental conditions with a 12-h light–
dark cycle. All procedures and housing of the animals were carried out according to 
the German Animal Welfare Legislation. Procedures involving animals were 
approved by Thüringer Landesamt für Verbraucherschutz, Abteilung Tiergesundheit 
und Tierschutz, Thüringen, Germany (Permit number: 02-122/12). 
 
Partial Hepatectomy  
All surgical interventions were performed under inhalation of 2 % isoﬂurane mixed 
with 0.3 L/min oxygen (Isoflurane vaporizer, Sigma Delta, UK). A precise vessel-
oriented, parenchyma-preserving piercing suture ligation method was used for 70% 
partial hepatectomy [22] in mice. In brief, after fully exposing the liver, a ligation (6-0 
silk, Ethicon, US) was performed 3 mm from the main branch of the left lateral 
hepatic vein for removing the left lateral lobe (LLL). Next, the gallbladder was 
removed after ligating the cystic duct and artery (7-0 prolene, Ethicon, US). One 
clamp was placed roughly perpendicular to the surface of the left median lobe (LML) 
and the LML was removed. After removing the lobe, one piercing suture was placed 
to ligate the left hepatic vessels. Thereafter, the right median lobe (RML) was 
clamped and removed in a similar way. After resection, two piercing sutures were 
placed to ligate the right and median hepatic vein as well as the arterial and portal 
supply. Finally, the abdomen was irrigated with warm saline solution and closed with 
a 2-layer running suture (6-0 prolene, Ethicon, US). 
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After operation, animals received a subcutaneous injection of 0.05 mg/kg (body 
weight) buprenorphine (Temgesic, Essex Pharma GmbH, Munich, Germany) to 
achieve analgesia. The animals were placed on a heating pad for postoperative 
recovery. 
In order to allow the comparison of vascular parameters of non-resected lobes before 
and after surgical resection and to eliminate the immediate effects of the surgery 
(details discussed below), a virtual resection was performed as explained below in 
the section “Obtaining Vascular Tree Representations”. 
 
Specimen Preparation  
Injection of a polymerizing silicone contrast compound (Microfil, Flow Tech Inc., 
Carver, US) (Fig.1-A) was performed on anesthetized normal mice and mice 
subjected to liver resection immediately after surgery, on postoperative day (POD) 2, 
and on POD 7 under anesthesia (n=3 for each time point and each group, PV and 
HV) [23]. Systemic heparinization was achieved by injecting heparinized saline (300 
U/kg) via the penile vein and waiting for 5 min for fully systemic heparinization. After 
laparotomy, portal vein was cannulated with a 26-gauge heparinized catheter and 
flushed with heparinized saline (0.4 ml/min) using a volume-controlled perfusion 
device (Perfusor VI, B. Braun, Melsungen, Germany) to remove the blood from liver 
and to prevent blood clotting. The mice were sacrificed by exsanguination after 
perfusion. Two specimen preparation methods were utilized. In the portal venous 
system, the silicone compound was injected into the liver via the catheter in portal 
vein. In the hepatic venous system, the infrahepatic inferior vena cava (IVC) was 
cannulated with another 26G catheter. After ligating the branches of the infrahepatic 
IVC and after clamping the suprahepatic IVC, the silicone compound was injected via 
the IVC into the hepatic venous system. 
The quality of silicone injection was monitored by the naked eye under the 
microscope throughout the procedure. 
After polymerization, the specimen was explanted (Fig.1-B) and weighed. 
Subsequently, the specimen was immersed in formalin for fixation.  
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Micro-CT Scanning  
The formalin-fixed specimens were scanned by µCT (Fig.1-C; Tomoscope Duo CT, 
CT Imaging GmbH, Erlangen, Germany). The µCT scans were performed using the 
scan-protocol HQD-6565-390-90 with 720 projections (approx. 1032 x 1012 pixels) 
during one full rotation with a scanning time of 90 s per subscan [24]. The scans 
resulted in voxel image representations (Fig.1-D) of the specimens at an isotropic 
resolution of 70 µm. 
Image Processing and Analysis 
After an initial quality check, part of the quantitative description of regeneration was 
obtained using the voxel image representation. Other parameters of the description 
were computed from an object-based representation obtained as described below. 
The parameters reported here reflect those parts of the vasculature resolved in the 
digital representations. 
The vascular system was visualized in 3D (Fig.1-F) based on the µCT images. For 
this purpose, image segmentation was performed by setting a threshold between the 
soft tissue intensity and the vessel intensity using the Imalytics Preclinical [25]. The 
resulting 3D vascular mask was visualized using surface rendering and inspected 
visually to assess the injection quality. Injection and subsequent imaging was 
classified as successful if segmentation resulted in the visualization of an intact 
vascular tree without ruptured structures.  
Circumscribed Parameters 
Circumscribed parameters (maximal vessel length, in/outflow vascular radii of the 
right inferior portal vein (RIPV) and right inferior hepatic vein (RIPV) were determined 
in the right inferior lobe (RIL).  
Measurement of maximal vessel length: The maximal vessel length of the right 
inferior portal/hepatic vein (RIPV/RIHV), i.e., the intravascular distance from root to 
most distant tip, was measured interactively based on the voxel images by Imalytics 
Preclinical software. A start point marker and an end point marker were placed at the 
root and distal end of RIPV/RIHV in 3D-vascular mask. The path line distance inside 
the vessel was determined as part of computing the “Path tortuosity”.   
Measurement of in/outflow vascular radius: Similarly, a start point and an end 
point were set at both sides of the vascular root to measure in/outflow vascular radius 
of the RIPV/RIHV. They were placed in the center of a vessel using a slice-based 
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view. The vessel diameters were computed by performing automatic analysis of 
“Elastic sphere diameters” [26]. The radius was calculated as half the diameter. 
 
Vascular Tree Representations 
Vascular tree representations of the whole/remnant liver were obtained from µCT 
imaging data as follows: 
First, a vascular graph representation of the vascular systems in the microfil 
specimens as well as a mask representation of the liver (both shown in Fig.1-E) and 
the different liver territories (Fig.1-G) was obtained applying a semi-automatic 
procedure for clinical liver surgery planning [27;28]. This procedure consists of (a) 
liver segmentation, (b) vascular segmentation, (c) conversion of portal vein and 
hepatic vein to graph structures, (d) labeling subgraphs according to the anatomic 
lobes, and (e) computation of the PV-supplied or HV-drained territories based on the 
liver segmentation (from step a) and labeled subgraphs (from step d). Organ volumes 
were immediately obtained from the liver masks. Similarly, the volumes of the 
territories were computed based on the territory masks. 
Second, the vascular graphs were converted to a tree representation (Fig.1-H) of the 
vascular systems as described in [21]. This result in strictly bifurcative trees with 
edges represented as cylinders, i.e., each branching connects one edge to two 
daughter edges, each edge geometrically has straight centerlines and constant 
radius, in other words represents a simplification of the actual vascular segment. 
Virtual Resection 
Virtual resection was performed using HepaVision software (Fraunhofer Institute for 
Medical Image Computing MEVIS, Bremen, Germany). After loading the vascular 
graph of whole normal liver in the software, vessels which supplied/drained the 
remnant liver lobes in the surgical resection (RIL, RSL, CIL, and CSL) together with 
portal stump or partial vena cava were selected and saved as a new graph. The 
vessels supplying/draining the LLL, LML and RML lobe were thereby omitted from 
the new vascular graph. The virtual remnant liver was considered as “liver after 
virtual resection” and was used to eliminate any additional influence of the surgical 
procedure. Similarly, the subgraph for the RIL was saved separately. Virtually 
resected liver and RIL subgraphs were separately converted to tree representations, 
in the same way as the full trees, for further separate analysis. 
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Cumulative Parameters 
The tree representation of the vascular systems permits an automatic computation of 
different quantitative parameters describing the geometry of the vascular system, 
based on the methods developed for [21;29]. 
Total edge length and total vascular volume for a given vascular tree were computed 
as the sum of all lengths and volumes, respectively, of the cylinders representing 
vascular edges. 
To characterize vascular density, vascular volume fraction was computed as the ratio 
of total vascular volume and parenchymal volume. Similarly, the ratio of total edge 
length and parenchymal volume was computed. 
Similarity of Branching Angles 
The similarity of the hepatic vascular systems before resection and at POD 7 was 
compared in terms of angular features. For this purpose, a scalar numerical measure 
of similarity as introduced in [21] was used. 
Each bifurcation can be fully characterized by three angles ϕa, ϕb, and ϕc [Fig. 1 in 
[21]]. Based on the classical Strahler orders [30], Strahler* orders were computed for 
each edge in the vascular tree, as explained in [21]. Histograms of each of the angles 
ϕ were computed for each order and each vascular tree. Two vascular trees were 
classified as ‘similar’ in terms of one of the angles ϕ and for a fixed order if a 
statistical two-sample Kolmogorov–Smirnov (KS) test [31] failed to detect a significant 
(p < 0.05, [32]) difference between the respective histograms. The overall angle 
similarity at a given observation time point, e.g., PV Normal, was then computed by 
comparing, for each angle ϕ and each order, each distinct pair of PV trees, and 
computing the fraction of ‘similar’ comparisons. Finally, the mean (over all angles ϕ) 
of the weighted averages (over the orders; weighted according to the number of 
edges with the given order) of these fractions was evaluated. This resulted in a 
number between 0 (no similarity) and 1 (high similarity).  
For a single group, this indicates intra-individual similarity. The similarity of two 
groups of vascular trees, e.g., PV Normal vs. POD 7, was computed in analogy to the 
procedure described above by comparing each normal PV to each PV at POD 7. 
Finally, an average over the three angles was computed. Detailed formulas for this 
quantification of similarity are given in [21]. 
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Characterizing the Growth Pattern 
Growth refers to a positive change in size over a period of time, in our case, includes 
vascular dilatation and vascular proliferation. The growth pattern was assessed with 
respect to isotropic expansion, defined as the increase of length by the same factor in 
all spatial directions.  
For this comparison, the observed changes of selected descriptive parameters 
(choice described below) were compared to those changes expected in case of 
hypothetical isotropic expansion. 
The descriptive parameters introduced above were based on the visible (i.e., digitally 
represented) vasculature. During regeneration, the liver increased its size. However, 
visibility is determined by the µCT resolution which is essentially independent of the 
specimen size and, in particular, independent of the time point relative to surgery. For 
hypothetical two specimens of the same liver before resection and at POD 7, the 
increase in visible vasculature would be due to two effects: (a) vascular edges 
exceeding the “visibility threshold” θ until POD 7 that were not yet visible before 
resection, and (b) growth of vascular edges already visible before resection. The 
latter vascular edges were denoted as “θ-visible” here to indicate that they are a 
subset of all visible edges, a precise criterion for θ-visibility (“thresholded visibility”) is 
given below. To quantify only the actual growth, the analysis was restricted to 
comparing parameters for the entire visible vascular trees before resection to 
parameters for the θ-visible part of the vascular trees at POD 7.  
Thresholding for Quantitative Comparison 
To define θ-visibility, a threshold θ for vascular radii was used. Generally, volume 
scales with the third power of length. Under the assumption of isotropic expansion, a 
relative change in length thus corresponds to the cubic root of the relative change in 
volume.  
Conversely and specifically for the data at hand: if ΔV denotes the relative volume 
change of the RIL from before resection to POD 7, the expected relative change Δd 
in length under the assumption of isotropic expansion is Δd =V1/3. So a threshold θ 
was chosen as θ=Δd times the minimal radius present in the vascular tree on POD 7. 
Under the assumption of isotropic expansion, any edges of radius ≥ θ would already 
have been visible in a hypothetical specimen of the same liver created before surgery. 
Thus, only edges of radius ≥ θ were used for further analysis. 
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Determining Parameters for Quantitative Comparison 
To compare the vascular growth pattern to hypothetical isotropic expansion, 
parameters which can be evaluated restricted to the θ-visible edges on POD 7 were 
selected from those above. These parameters were (a) in/outflow vascular radius, (b) 
total vascular length, (c) total vascular volume, (d) total vascular length/volume, and 
(e) vascular volume fraction.  
In/outflow vascular radius of the RIL is always θ-visible since it was measured at the 
root of the vessel, so no new determination was needed for POD 7. The other 
parameters are affected by θ-invisibility and were thus re-evaluated restricted to θ-
visible edges on POD 7 (“observed values”). 
Estimating the Effect of Isotropic Expansion 
Based on ΔV, defined above as the relative volume change of the RIL from before 
resection to POD 7, “expected values” were obtained by scaling the parameter from 
before resection by appropriate scaling factors. These scaling factors are the relative 
change in length (Δd =V1/3, see above) to the power of the dimension of the 
respective parameter, i.e., V1/3 for in/outflow vascular radius and total vascular length, 
V3/3=V for total vascular volume, V-2/3 for total vascular length/volume, and ΔV0/3=1 for 
the vascular volume fraction (i.e., the latter should remain constant). 
Finally, observed and expected values were compared to estimate the extent of 
growth. In addition, further insight into the growth pattern was gained by quantifying 
changes in angular features.  
Comparing Angular Features 
Purely isotropic expansion does not change any angles at bifurcations. Given that 
specimens before resection and at POD 7 were obtained from different animals, no 
1:1 comparison was possible. Instead, the similarity of branching angles between the 
two time points was compared to the intraindividual similarity at the separate time 
points. If those similarities were in the same range, this was used as an indicator 
supporting the hypothesis of purely isotropic growth. 
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Results 
Visualization and Quantification of Regeneration 
Based on the macroscopic appearance and visualizations (Fig.2), parenchymal 
regeneration is described qualitatively as three-dimensional growth of the remaining 
liver lobes. Vascular regeneration in both portal and hepatic venous system 
appeared to be as elongation and widening of the main vascular structures in 
combination with an out-branching of smaller vessels. Starting on POD 2, the 
vascular trees of remnant lobes elongated. By POD 7, additional small branches from 
the same main portal vein and hepatic vein became visible.     
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Quantification of Parenchymal Regeneration 
Quantitative analysis focused on evaluation of parameters indicative of parenchymal 
and vascular liver regeneration at different observation time points after 70%PH.  
Liver weight recovery was compared to computed liver volume recovery, resulting in 
the relation: hepatic volume (in ml) = 0.907 × liver weight (in gram) + 0.053. These 
two hepatic parameters indicative of parenchymal regeneration were highly 
correlated (r2=0.97, p<0.001), for all individual cases in both portal and hepatic 
vascular system. The average density (± standard deviation) of the livers was 1.042 ± 
0.050 g/ml, which is nearly the same as the liver density of humans (1.051 ± 0.013 
g/ml) [33]. The increase of hepatic volume paralleled the increase of liver weight 
(Fig.3-A), indicating that the increase of hepatic volume can be utilized as basis for 
the subsequent quantitative analysis of hepatic parenchymal regeneration. 
In normal mice, total liver weight ranged from 1.3 to 1.6 g. Similarly, total computed 
liver volume ranged from 1.2 to 1.6 ml, irrespective of the vascular tree used for the 
computation (1.35 ± 0.16 ml in PV group and 1.35 ± 0.20 ml in HV group)  (Fig.3-B). 
Hepatic volume of the remnant liver was slightly lower after virtual resection 
compared with the volume after surgical resection. Virtual resection in the PV/HV 
group resulted in a decrease of mean total hepatic volume to 35% respectively 34%, 
whereas surgical resection resulted in a remnant hepatic volume of 52% to 48%. The 
observed volume difference between virtual resection and surgical resection may be 
attributed to the complete removal of the liver lobe after virtual resection. In contrast, 
surgical removal of a liver lobe results in a stump which contributes to the volume of 
the remnant liver, leading to a slightly higher remnant liver volume.  
Hepatic volume after virtual resection increased from 0.45 ml in PV-group 
respectively 0.46 ml in the HV group to about 1.22 ml and 1.19 ml at POD 7. This 
volume represented about 90% of the starting volume and was equivalent to a 
2.7/2.6-fold increase. Similar results were reported when studying liver weight 
recovery in mice [34].  
The volume recovery of the RIL was very similar compared to the total liver volume 
recovery, indicating a similar parenchymal growth of the liver lobes of the liver lobes. 
Before surgery, the volume of RIL was 0.16 ± 0.02 ml in PV group and 0.17 ± 0.03 ml 
in HV group. By POD 7, it reached about 0.41 ml and 0.44 ml, representing a 2.6/2.7-
fold increase compared to the mean volume after virtual resection in the PV/HV 
group.   
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Quantification of Vascular Regeneration 
Assessment of vascular regeneration was based on a comparison of different 
parameters obtained on POD 7 and after virtual resection. This time point was 
chosen as the initial state to exclude immediate effects of the surgical intervention. 
First, vascular radii and maximal vessel lengths of the main right inferior 
portal/hepatic vein were measured and compared between different time points 
(circumscribed data for individual vessels). Next, total edge length and total vascular 
volume for the whole/remnant liver and separately for the RIL were computed 
(cumulative data for the vascular trees). Finally, parameters describing the vascular 
density, i.e., total edge length/hepatic volume and the vascular volume fraction were 
considered. 
Individual Vessels 
Vascular radii of RIPV and RIHV (Fig.4-A) increased, albeit to a different extent. 
Starting from mean in/outflow vascular radius of 0.35 ± 0.02 mm (PV group) and 0.47 
± 0.01 mm (HV group), radii increased by 1.3- and 1.1-fold respectively until POD 7 .  
When comparing the RIPV-radius after virtual resection with the radius obtained after 
surgical resection, a substantial difference was observed, suggesting an effect of 
portal hypertension. A further increase was observed when comparing the radius 
after surgical resection and the radius at POD 2. This increase could be the result of 
vascular growth but also of vascular dilatation, which cannot be discriminated based 
on the imaging data.  
In contrast, the radius of the RIHV remained rather similar until POD 2 and increased 
thereafter, an observation better attributable to vascular growth.  
However, average maximal vessel length of both vascular systems (Fig.4-B) 
increased in parallel during regeneration. Before surgery, the maximal vessel length 
was 12.43 ± 0.87 mm (PV group) and 10.59 ± 0.62 mm (HV group). Immediately after 
surgical resection, maximal vessel length remained almost the same. By POD 7, 
maximal vessel length of RIPV as well as RIHV increased both up to 1.3-fold.   
Vascular Trees 
In contrast to the maximal vessel length, the total edge length increased after surgical 
resection compared to virtual resection.  
In normal mice, the total edge length of whole liver (Fig.4-C) was 861.93 ± 179.45 
mm in the PV group and 875.87 ± 118.87 mm in the HV group. As expected from the 
resected volumes after virtual resection, it decreased to 38% and 45% in the PV 
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group and HV group corresponding to 326.62 ± 75.43 mm in the PV group and 
394.35 ± 55.03 mm in the HV group.   
However, total edge length was substantially higher after surgical than after virtual 
resection (568.39 ± 45.94 vs. 326.62 ± 75.43 mm in the PV group and 486.04 ± 
22.41 vs. 394.35 ± 55.03 mm in the HV group). On the one hand, this might be due to 
portal hypertension induced vascular dilatation caused by surgical resection (see Fig. 
S1). Small terminal vessel branches in both vascular systems, which were invisible in 
normal liver, might have been dilated and thereby became visible, which contributed 
to the computed total edge length. On the other hand, the vessels of the remnant 
stump after surgical resection were taken into account when computing the total edge 
length. However, the influence of the small stumps to the total edge length of the 
remnant liver was limited and negligible since the visible vascular trees were rather 
small.   
The total edge length in both portal venous and hepatic venous tree recovered fully 
by POD 7. By POD 7, total edge length increased by 2.8-fold and 2.3-fold in PV/HV 
group, respectively. Similarly, RIL edge length increased by 2.6-fold and 2.2-fold in 
PV/HV group. 
Total vascular volume differed between PVs and HVs (Fig.4-D). In the PV group of 
whole livers, volumes (0.071 ± 0.008 ml) were lower than in the HV group (0.152 ± 
0.010 ml) where the volume of the inferior vena cava was also included.  
Also for this parameter, we observed a difference between surgical and virtual 
resection. Total vascular volume in the PV group after surgical resection was slightly 
higher than after virtual resection (0.035 ± 0.006 ml vs. 0.024 ± 0.003 ml). In the HV 
group, total vascular volume after surgical resection was slightly lower than after 
virtual resection (0.084 ± 0.008 ml vs. 0.094 ± 0.011 ml). This might be an indirect 
effect of portal hypertension leading to a dilation of portal vessels and consecutively 
leading to a compression of the hepatic venous tree [35].  
Despite the absolute differences in the total volume of both vascular trees, the 
relative volume increases during the regenerative process in both groups were 
almost comparable. By POD 7, there was a 2.6-fold increase in the PV group and 
1.5-fold increase in the HV group, leading to an 89% to 94% recovery within one 
week. Similar observations were obtained for both vascular trees of the RIL. 
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Branching angles stayed essentially the same during regeneration, indicating, at first 
glance, that the growth pattern resembled isotropic expansion. Branching angles at 
the bifurcations (see Fig. 5) exhibited a high similarity among the normal livers, 0.926 
in both the PV and the HV group. These similarities are even larger than previous 
results for entire mouse livers (0.841 vs. 0.710) reported in [Fig. 2 in [29]], and show 
a slightly higher similarity among PVs than for HVs also in our data. Among the livers 
at POD 7, lower similarities of 0.916 and 0.879 (among the PV and HV groups, 
respectively) were observed. In both cases, the tendency of PVs being more similar 
than HVs in terms of branching angles could be confirmed, (see [29] for results in 
mice and [21] in humans). The similarity of normal PVs and those at POD 7 was 
0.900 and thus not substantially lower than at the separate time points (0.853 for 
HVs), showing that branching angles do not change considerably during regeneration. 
 
Relating Parenchymal and Vascular Regeneration 
Vascular Density 
Given the fact that the extrahepatic part of the vascular systems could not be 
excluded from the vascular trees due to the technical reasons, the calculation of 
these parameters describing vascular density (vascular volume fraction and total 
edge length/hepatic volume) were based on a selected liver lobe (RIL).  
Similar to previously mentioned parameters, vascular density also seems to be 
affected by the surgery-induced portal hypertension as expected based on the edge 
length and vascular volume described above (see also Fig.4-C and -D). We observed 
an increase of PV edge length/RIL hepatic volume and a decrease of HV edge 
length/RIL hepatic volume after resection, possibly also an indirect effect of portal 
hypertension. During the course of regeneration, this density returned to the values 
before surgery, see Fig.6-A. 
In contrast, the PV volume fraction increased substantially when comparing the RIL 
before and after resection but reached its maximum on POD 2. This could be 
explained by portal hypertension still being present, while parenchymal volume is not 
fully recovered on POD2. The HV volume fraction followed the same kinetic pattern 
as described for the HV length/RIL volume, see Fig.6-B. 
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Observed Growth Pattern 
To characterize the observed growth pattern, relative changes of the parameters 
above were computed and compared. 
In the PV group (Fig.7-A), the relative increase of vascular radius and maximal vessel 
length of the RIL (1.4-fold and 1.3-fold) was not that obvious compared to the 
remaining three parameters: Hepatic volume indicative of parenchymal regeneration 
increased to 2.6-fold. Total edge length and total vascular volume of RIL increased to 
2.6-fold and 4.9-fold, revealing that the radius of vascular branches in the periphery 
increased in parallel to the radius at the inflow. 
Similar results were obtained when computing the relative increase of vascular radius 
and maximal vessel length in the HV group (1.1-fold and 1.3-fold) (Fig.7-B). The 
relative increase of hepatic volume in the HV group (2.7-fold) was comparable to the 
PV group. However, there was a slight difference between the increase of RIL edge 
length and vascular volume in the PV and HV group. In contrast to the PV group, the 
increase of total edge length of RIL (2.2-fold) was higher than the increase of 
vascular volume (2.0-fold) in the HV group. This indicates that the radii in the 
periphery increased less than the radii at the outflow. 
In the PV group, RIL edge length/hepatic volume (Fig.7-C) increased to 1.2-fold 
immediately after surgical resection. One likely reason could be that the total edge 
length was enlarged due to the increase of edge visibility caused by portal 
hypertension-induced vascular dilatation whereas portal hypertension has limited 
influence to hepatic volume. Altogether, the increase of total edge length was much 
higher than the increase in hepatic volume leading to a big increase in RIL edge 
length/hepatic volume right after resection. In contrast to the PV group with a slight 
increase, RIL edge length/hepatic volume in the HV group had a slight decrease after 
surgical resection; both with a tendency to recover within the 7 observed days.  
The relative changes of vascular volume fraction (Fig.7-D) were different from the 
changes of RIL edge length/hepatic volume. Vascular volume fraction increased 
considerably by POD 7 in the PV group (1.9-fold). However, in the HV group, it 
decreased to 52% after surgical resection, recovered to 76% of normal ranges by 
POD 7. 
These findings could be explained by portal hypertension after resection leading to a 
dilation of the portal vein tree, and a corresponding compression of the hepatic vein 
tree.  
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Comparison of the Observed Growth Pattern to Isotropic Expansion 
Taking all data together revealed that the relative increase of parenchymal volume 
outweighed the relative vascular elongation, suggesting that it could be explained by 
isotropic expansion. This suspicion is further corroborated by the lack of changes in 
the branching angles, as only non-isotropic growth can distort bifurcations. The 
increase of parenchymal volume in the RIL was 2.6-fold (PV group; 2.7-fold for the 
HV group), whereas the increase of the maximal vessel length was 1.3-fold. In case 
of isotropic expansion, the 2.6-fold volume increase would correspond to a 1.4-fold 
increase of lengths and radii. In order to better compare the observed growth pattern 
of liver regeneration to isotropic expansion, a more elaborate analysis was necessary. 
The observed relative increase in the parameters describing the vascular system 
before resection and at POD 7 were compared to the expected increase in case of 
isotropic expansion, see Fig. 8.  
In the PV cases, the increase of inflow vascular radius almost perfectly matched the 
expected increase in case of isotropic expansion. Total edge length and total edge 
length/hepatic volume were about 20% lower than expected in case of isotropic 
expansion, whereas the vascular volume and the vascular volume fraction were 
about 60% larger. This indicates that the vascular radii in the periphery increased a 
lot more than expected. In the HV cases, the outflow vascular radius was about 20% 
lower than the expected increase in case of isotropic expansion, the remaining 
parameters (total edge length, total edge length/hepatic volume, vascular volume, 
vascular volume fraction) were about 40% lower than the expected increase in case 
of isotropic expansion. This could indicate that HVs generally grow/regenerate slower 
than PVs. 
In summary, the changes in the vascular systems, combined with differences 
between HVs and PVs, contradict the hypothesis of isotropic expansion of liver 
parenchyma and vascular structures. 
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Discussion 
In this study, we quantitatively described parenchymal and vascular regeneration 
after PH in mice, and compared the observed hepatic regeneration to hypothetical 
isotropic expansion. For this purpose, we established the presented framework for 
high-resolution μCT imaging and qualitative and quantitative analysis of the vascular 
system in normal and resected mice.   
Assessment of liver parenchymal regeneration based on computed volumes is a 
reasonable approach for several reasons: Liver weight and volume were strongly 
correlated (see Fig. 3), the resulting density was similar to literature results [33], and 
the observed volume recovery within one week was comparable to previously 
published findings [37] for both the PV and HV group in this study. 
Assessment of the vascular system based on vascular geometry provided 
information regarding vascular regeneration which cannot be obtained otherwise, e.g., 
by classical parameters such as determination of the proliferation rate of the 
endothelial cells.  
Regeneration is not Isotropic Expansion 
Relating hepatic parenchymal and vascular growth as well as the similarity of 
branching angles suggested, at first glance, that regeneration resembles isotropic 
expansion and thus permits an easy descriptive model. For further investigating the 
growth pattern, a more detailed analysis was performed: changes in descriptive 
geometric parameters were compared to those changes expected in case of isotropic 
expansion. To achieve this comparison, the vascular datasets were thresholded to 
eliminate the influence of increased visibility of vasculature that would not have been 
visible in a hypothetical scan of the same individual at an earlier time point (θ-
invisible edges). Ultimately, the observed changes were not compatible with the 
hypothesis of isotropic expansion. These observations indicated that hepatic 
regeneration might be a more complex process influenced by many factors.  
One important factor is portal hypertension. Portal hypertension induced by surgical 
removal of liver lobes (see Figure S1) might affect these vascular parameters to 
different extent, not only immediately after resection but also even after 7 days.  
In order to investigate immediate effects of surgery, we compared vascular 
parameters obtained after surgical resection to after virtual resection. We observed 
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that portal hypertension affected the vascular diameter strongly and the vascular 
length slightly. These effects were more pronounced in the PV system than the HV 
system. Here we suggest a cautious interpretation of the respective quantitative data 
in the early phase of liver regeneration, as it is impossible to discriminate vascular 
dilatation from vascular growth based on geometric data. In consequence, results 
from the virtual resection group should serve as control when assessing regeneration 
in terms of total edge length and total vascular volume of the regenerating remnant 
liver. 
We also considered potentially longer-lasting effects of portal hypertension on 
vascular geometry. Based on two observations, we conclude that portal 
hypertension/perfusion may have a persisting effect on the vascular system: On the 
one hand, PVP has returned to normal ranges after one week (Fig. S1). On the other 
hand, the geometric parameters and in particular the differences between PVs and 
HVs on POD 7 (Fig. 7) showed patterns that could be a residue of portal 
hypertension. However, further work is needed to determine the 3D-growth pattern of 
regenerating livers and to elucidate the underlying biological processes in targeted 
studies. 
Limitations 
The presented approach using silicone injection, µCT imaging of explanted liver 
specimens and image analysis is useful for quantifying vascular geometries based on 
standard imaging techniques. It permits the assessment of differences between 
different post-surgical time points. Still, certain technical limitations should be taken 
into account when interpreting the resulting data. 
First, using the explanted livers from different animals for each time point leads to the 
side effect of introducing inter-individual variation. Promising technologies are under 
development allowing repeated in-vivo assessment of the same animals [12], 
allowing monitoring the kinetic of vascular regeneration of an individual liver. This 
would permit a better comparison of vascular growth at different time points.  
Second, in the HV specimens, the intrahepatic vena cava could not be excluded from 
silicone injection, leading to artificially large vascular volumes. When comparing 
between different time points for the entire liver, this mainly affected vascular 
volumes, whereas the influence on the other vascular geometric parameters was 
negligible. The analysis of the RIL as a single lobe remained unaffected by this 
artifact and was therefore performed. Furthermore, a slight discrepancy between 
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physiological vascular geometry and the silicone-injected specimens might be 
present. 
Third, image resolution in the workflow used here was limited to 70 µm, focusing the 
investigation on changes in the larger vasculature rather than on angiogenesis 
occurring at smaller length scale [38]. In the subsequent image analysis, radius and 
centerline position estimation led to differences between measurements in voxel 
image data and graph representation. This procedure is known to slightly 
underestimate vascular volumes [39]. The simplification from vascular graph to 
vascular tree again led to differences in measurements of lengths, radii, and angles. 
Moreover, calculating the total vascular volume as sum of vessel represented 
cylinder volume, overlap/gaps were ignored, introducing two more inaccuracies that 
only partly compensate for each other. Finally, the concept of θ-visibility could be 
insufficient to eliminate the influence of increased visibility of vasculature that would 
not have been visible in a hypothetical scan of the same individual at an earlier time 
point. Determining the relative importance of these uncertainties on the overall 
quantitative results will require a detailed sensitivity analysis. This, however, is 
beyond the scope of the present study. 
Future applications 
The workflow presented in this study is modular in the sense that it can (a) be applied 
to various organs, (b) use other imaging modalities (e.g., other contrasting media, 
other and higher imaging resolution, in vivo scans, MRI), (c) employ different 
approaches to obtain tree representations of the vasculature, and (d) evaluate 
additional geometric parameters if deemed relevant. In particular, the methods used 
here can also be applied to (potentially smaller) specimens scanned at higher 
resolution to assess changes in finer vasculature, including investigating 
angiogenesis [6]. 
Quantitative descriptions of vascular regeneration and, in particular, its spatial 
inhomogeneity, provide useful information. It can help to identify disturbances in liver 
regeneration, which is a prerequisite for possibly developing treatment strategies.  
Quantitative descriptions of vascular systems are of utmost importance for perfusion 
studies. Perfusion is, in turn, the basis for distribution of substances from the 
organism to the liver and in particular for pharmacokinetics. Vascular regeneration 
thus leads to alterations in pharmacokinetics. Quantifying vascular regeneration can 
be used to extend PK simulations with spatially resolved livers [40;41] towards 
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regenerating livers. This approach could be further used to extend simulations 
involving lobular regeneration [42] to the scale of the entire organ. Ultimately, this 
could help optimizing therapy for patients undergoing liver regeneration. 
This study is an important prelude to further studies on vascular regeneration. In the 
future, the techniques presented here can be applied in a broad range of conditions 
associated with the changes of vascular features. Findings could be used as input or 
for validation of regeneration/growth simulations including vascular structures, e.g., 
combining approaches like [43] and [29] or as input for simulations estimating the 
recovery of liver function after resection. 
Conclusion 
We successfully implemented a workflow for quantifying vascular regeneration in 
resected mouse livers. The observed growth pattern turned out to be more complex 
than mere isotropic expansion. Prospectively, this quantification approach can be 
used for investigating hepatic vascular regeneration under different conditions. 
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Figures 
Figure 1 
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Fig 1. Workflow Sketch. At different time points before and after partial hepatectomy, 
silicone contrast compound was injected into either portal vein (shown here; naïve 
liver) or hepatic vein of a mouse liver (A). The liver was explanted (B) and imaged in 
a micro-CT scanner (C). The resulting voxel image data (D) was thresholded and 
visualized as a surface rendering (F), where the measurements of maximal vessel 
length and radius of RIL were performed interactively. From (D), the liver was 
segmented and the vascular system was segmented and skeletonized, resulting in a 
graph representation visualized in (E) along with the liver mask. Manually labeling the 
vascular graph according to anatomical lobes, the respective supplied territories were 
computed (G; territories shown in different color), permitting both qualitative visual 
assessment and quantitative volume measurements. The vascular graphs from (E) 
were converted to strictly bifurcative trees (H, here colored according to Strahler* 
order [21]). Based on these, automatic measurements of lengths, radii, and angles 
were performed. 
Image credits: The eye and spreadsheet icons at the bottom were adapted from 
https://openclipart.org/detail/216030/eye-lineart and 
https://openclipart.org/detail/198552/mono-spreadsheet. Photos in (B) and (C) were 
edited to remove 
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Figure 2 
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Fig 2. Visualization of liver regeneration. Parenchymal and vascular regeneration 
in the PV group (A) at indicated time points following partial hepatectomy. Left lateral 
lobe (visualized in green), left median lobe (visualized in yellow), and right median 
lobe (visualized in dark blue) were removed during PH. These lobes did not regrow 
during the whole regenerative procedure. Vascular regeneration in both portal and 
hepatic venous system appeared as elongation of the main vascular structures in 
combination with an out-branching of smaller vessels.  Parenchymal and vascular 
regeneration in HV group (B) were in parallel to the growth in the PV group. 
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Figure 3 
 
Fig 3. Quantification of Parenchymal Regeneration. (A) Correlation of liver weight 
and liver volume. Liver weight was compared to computed liver volume, resulting in 
the relation hepatic volume (in ml) = 0.907 × liver weight (in gram) + 0.053. These 
two hepatic parameters indicative of parenchymal regeneration were highly 
correlated (r2=0.97, p<0.001). (B) Recovery of hepatic volume of total liver and right 
inferior lobe within the first postoperative week (mean ± SD, n=3/time point). In PV 
group, virtual resection resulted in a volume reduction from 1.35 ± 0.16 ml to 0.45 ± 
0.05 ml, representing a loss of about 70% of the total hepatic volume. In contrast 
surgical resection caused a reduction to 0.70 ± 0.06 ml, suggesting surgical removal 
of a liver lobe results in a stump which contributes to the volume of the remnant liver. 
Liver volume reached 1.22 ± 0.06 ml, representing a 90% recovery. The hepatic 
volume recovery was almost in parallel in the HV and PV group. 
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Figure 4 
Fig 4. Quantification of Vascular Regeneration. Vascular radius (A) of the right inferior 
portal vein increased substantially until POD 2 and remained stable thereafter. In contrast, 
the radius of the right inferior hepatic vein remained rather similar until POD 2 and increased 
thereafter. However, average maximal vessel length (B) of both vascular systems increased 
in parallel during regeneration. Total edge length (C) in PV group reduced from 861.93 ± 
179.45 ml to 326.62 ± 75.43 ml comparing before and after virtual PH, representing a loss of 
62% of the total edge length. In contrast, surgical PH caused a reduction to 568.39 ± 45.94ml, 
suggesting an effect of portal hypertension. It reached 929.76 ± 308.88 ml, representing a 
1.1-fold increase. The increase of total edge length in HV group was almost in parallel in the 
PV group. However, total vascular volume (D) differed between PVs and HVs. We observed 
an increase of total vascular volume after surgical resection compared to after virtual 
resection in PV group but a decrease in HV group. The increases during the regenerative 
process in both vascular systems were almost comparable. 
                                            MANUSCRIPT III 72 
 
Figure 5 
 
Fig 5. Similarity of Angular Parameters. For time points Normal and POD 7, the 
plot shows the inter-individual similarity of the angular parameters describing 
bifurcations for the vascular trees of the RIL, as well as the similarity between the 
respective vascular trees at the two time points. The similarity measure from [21] is a 
value between 0 (low) and 1 (high similarity). 
 
Figure 6 
 
Fig 6. Relating Parenchymal and Vascular Regeneration in RIL.  (A) RIL edge 
length/RIL hepatic volume. We observed an increase of RIL edge length/RIL hepatic 
volume in the PVs and a decrease of RIL edge length/RIL hepatic volume in the HVs 
after resection. This density returned to the values before surgery after 7 days’ 
regeneration. (B) Vascular volume fraction of RIL in PVs increased substantially 
when comparing the fraction before and after resection but reached its maximum on 
POD 2. However, the vascular volume fraction in HVs followed the same kinetic 
pattern as described for the HV length/RIL volume. 
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Figure 7 
 
Fig 7. Relative changes of regenerative parameters. The relative changes of five 
parenchymal and vascular regenerative parameters in PV group (A) and in HV group (B) 
were related. After 1 week, vascular radius and maximal vessel length in PV group increased 
to 1.4-fold and 1.3-fold compared with after virtual resection, hepatic volume increased to 
2.6-fold, total edge length and total vascular volume increased to 2.6-fold and 4.9-fold, 
revealing that the radius of vascular branches in the periphery increased in parallel to the 
radius at the inflow. The relative increases of vascular radius, maximal vessel length and 
hepatic volume were comparable in HV group and in PV group. However, RIL edge length 
and vascular volume increased not as pronounced as in PV group, to 2.2-fold and 2.0-fold 
respectively. This indicates that the radii in the periphery increase less than the radii at the 
outflow. The relative changes of these two derived parameters referred to vascular density, 
RIL edge length/hepatic volume (C) and vascular volume fraction of RIL (D) were compared. 
The increase of total edge length was much higher than the increase in hepatic volume 
leading to a big increase in RIL edge length/hepatic volume right after resection in the PV 
group. In contrast, RIL edge length/hepatic volume in the HV group had a slightly decrease 
after surgical resection. 
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Figure 8 
 
Fig 8. Comparison to Isotropic Expansion. (A) The plot shows the expected 
increase in case of isotropic expansion and observed relative changes for the RIL 
from before surgery to θ-visible parameters at POD 7. The expected values 
(rectangular part of the bar) are computed for the change of mean volume of the RIL 
from Normal to POD 7, assuming isotropic expansion. Color of the triangle showing 
direction of difference (blue = observed value is smaller; yellow = observed value is 
larger) 
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Supporting Information 
S1 Figure 
  
S1 Fig. Portal vein pressure (PVP) after 70% partial hepatectomy. PVP was 
measured by inserting Millar catheter into the confluence of portal vein at indicated 
time points. Average PVP before resection was 6.9 ± 2.4 cmH2O. It increased to 11.4 
± 2.9 cmH2O immediately after surgical resection (Data were reported in [36]). It 
returned to normal ranges on POD 7 (7.8 ± 0.3 cmH2O). This revealed that as the 
new vessel bed developed, the influence of portal hypertension was reduced. 
S1 Table. Data evaluation of parenchymal and vascular parameters. 
S1 Dataset. Vascular tree datasets used in the geometric analysis. Vascular 
trees are stored in text format, can thus be read using any text editor or imported in 
spreadsheets, and viewed interactively in 3D using the viewer tool from [Data S1 in 
[40]] 
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Summary 
In this study, we visualized and quantified hepatic parenchymal and vascular 
regeneration after modulating CXCR4-CXCR7-SDF-1α axis by applying either 
AMD3100 (CXCR4 antagonist) or TC14012 (CXCR4 antagonist and CXC4 agonist) 
in 70% PH mouse model. We observed that only by blockade of CXCR4 using 
AMD3100 had limited role in liver regeneration after 70%PH. However, liver 
regeneration was impaired by administrating TC14012, CXCR4 antagonist and 
CXCR7 agonist. These results in pilot experiment indicated that, blockade of CXCR4 
by AMD3100 after hepatectomy was not capable of inhibiting angiogenesis and 
vascular growth, because it might be by the compensatory actions through an 
alternative SDF-1α receptor CXCR7. 
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Abstract  
Background 
Liver regeneration consists of parenchymal regeneration and hepatic vascular growth. 
SDF-1α and its receptors CXCR4 and CXCR7 are involved in vascular growth during 
vasculogenesis and angiogenesis. However, the role of this pathway for hepatic 
parenchymal and vascular regeneration was not yet well explored due to the lack of 
appropriate methods. We recently established a work flow consisting of contrasting 
the vascular tree using a silicone compound injection method, micro-CT imaging 
technique and subsequent image data analysis to quantitatively assess hepatic 
vascular growth during liver regeneration  
The aim of this study was to visualize and quantify hepatic parenchymal and vascular 
regeneration after modulating CXCR4-CXCR7-SDF-1α axis in 70% PH mouse model. 
Two drugs were selected for modulating CXCR4-CXCR7-CXCL12 axis:  (1) CXCR4 
antagonist, AMD3100, for blockade of CXCR4 and (2) CXCR4 antagonist and 
CXCR7 agonist, TC14012, for blockade of CXCR4 and activation of CXCR7. We 
hypothesized that after blockade of CXCR4 and activation of CXCR7, liver 
regeneration would be impaired. 
Method 
Mice were subjected to 70% partial hepatectomy (PH) (70%PH group, n=6/time 
point).  AMD3100 (10 mg/kg/day, 70%PH+AMD3100 group, n=6/time point) and PBS 
(70%PH+PBS group, n=6/time point) were administrated by an osmotic pump. 
TC14012 (5 mg/kg/day, 70%PH+TC14012 group, n=4/time point) was injected 
subcutaneously every post-operative day before sacrifice. Naïve mice (n=6/time point) 
and mice subjected to sham operation (n=6/time point) served as control groups.  
Postoperative monitoring included daily recording of the body weight for calculating 
body weight recovery. Liver specimens were explanted and weighed for determining 
liver weight to body weight ratio. The BrdU.proliferation index was determined in 4 
different remnant liver lobes. Three liver specimens in 70%PH+TC14012 group were 
injected with silicone compound and subjected to µCT scanning. Three dimensional 
vascular trees and the hepatic territories were reconstructed based on µCT data 
using Imalytics Preclinical software. Maximal vessel length of right inferior portal vein 
(RIPV) and the radius of inflow RIPV were measured as well. 
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Results  
Blocking the CXCR4 using the antagonist AMD3100 did not neither affect 
parenchymal regeneration nor vascular growth. However using TC14012 with a 
simultaneous effect on both CXCR4 and CXCR7 was associated with a lower 
parenchymal recovery on POD 2 and 7 as indicated by the LW/BW ratio and the 
significantly lower liver cell proliferation rate and a reduced vascular growth (maximal 
vessel length and radius of RIPV on POD 2 and 7 substantially lower compared to 
the PBS treated group). 
Conclusion  
Our results elucidated that the blockade of CXCR4 by AMD3100 after hepatectomy is 
not capable of inhibiting angiogenesis and vascular growth. This finding might be 
explained by compensatory actions through the alternative CXCL12 receptor CXCR7. 
This interpretation is further supported by our observation of a reduced and delayed 
course of liver regeneration, when applying TC14012, a compound not only blocking 
CXCR4 but also activating CXCR7. Further investigations e.g. focusing on a CXCR7 
agonist such as CCX771whichonly plays a role in blocking CXCR7, are needed for 
better understanding of the molecular mechanism of SDF-1 and its two receptors. 
 
Introduction  
 
CXCR4-CXCR7- SDF-1α pathway is important in vasculogenesis and angiogenesis 
[1] in normal injured tissue and in tumor.  
SDF-1α is a chemokine that acts through its receptors CXCR4 and CXCR7. The 
tissue and serum expression levels of SDF-1α and CXCR4 are upregulated after liver 
injury [2;3].  It was observed recently, that upregulation of SDF-1α initiated liver 
regeneration by activating LSECs through autocrine/paracrine pathways [4] and 
through the mobilization of hematopoietic cells [5]. However, how this pathway may 
affect hepatic vascular regeneration still remains elusive.  
Thus, we aimed at studying the influence of this pathway on hepatic vascular 
regeneration using our newly developed workflow for quantifying vascular 
regeneration (see details in Manuscript III). In brief, this workflow consists of injecting 
silicone contrast compound followed by explanting the liver and ex-vivo µCT 
scanning and quantitative analysis of the 3D reconstructed vascular tree.  
We decided to modulate CXCR4-CXCR7-SDF-1α pathway by pharmacological 
interventions and study the effects in liver regeneration after 70%PH. Two reagents, 
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AMD3100 and TC14012, were chosen for this purpose. AMD3100 is a specific 
CXCR4 antagonist that inhibits binding and the function of SDF-1α with high affinity 
and potency [6] and subsequently inhibits CXCR4 calcium signaling [7], which might 
impair liver regeneration.  
In contrast, TC14012 is not only CXCR4 antagonist but also CXCR7 agonist. 
TC14012 is a much more potent agonist on CXCR7 (EC50 of 350 nM for TC14012 
versus 140 μM for AMD3100) and only one log weaker than the natural chemokine 
agonist SDF-1α (35 nM) [8]. TC14012 can activate the β-arrestin pathway via 
activation of GRK, leading to internalization of CXCR4 and scavenging of SDF-1α. 
Thus, we hypothesized that liver regeneration will be impaired by applying TC14012. 
 
Methods 
1. Partial Hepatectomy  – as described in method section of Manuscript III 
2. Drug administration 
2.1 AMD3100/PBS administration 
AMD3100 (Sigma Aldrich, Saint Louis, Missouri, US) was applied in a 
concentration of 10 mg/kg/day [9] using an osmotic pump (1007D, ALZET® 
Pumps, Charles River Laboratories International, Inc.). Osmotic pump was filled 
with AMD3100 or PBS and immersed in saline solution at room temperature 8h 
before implantation. A small incision on the back side of the mouse neck was 
made after resection for pump implantation.  
2.2 TC14012 administration  
TC14012 was applied in a concentration of 5 mg/kg/day. TC14012 was injected 
subcutaneously immediately after surgery and at every post-op day  
3 Body weight recovery 
Body weight was determined daily. Body weight recovery (%) and used to assess the 
systemic effect of the surgical procedure and drug administration on body weight 
development and was calculated based on the formula below: 
Body weight recovery% = BW on every post-OP day [g]/ BW on OP day [g] *100% 
4 Clinical chemistry  
Serum for measuring the levels of liver enzyme was obtained when harvesting and 
stored at -80C until measurement. The serum levels of aspartate transaminase (AST), 
alanine transaminase (ALT) were measured using Automated Chemical Analyser 
(Bayer Advia 1650, Leverkusen, Germany).  
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5 LW/BW ratio  
Liver weight measured on harvesting day was compared with the mouse body weight 
on operation day for estimating liver weight recovery.  
LW/BW ratio= Liver weight on sacrifice day [g]/ body weight on operation day [g]*100% 
6 BrdU proliferation index 
Mice were injected with 5-bromo-2'-deoxyuridine 1 hour prior to sacrifice. The 
formalin fixed liver tissue was embedded in paraffin and cut in 4µm thick sections. 
Thereafter, slides were stained with Bromodeoxyuridine (BrdU). The total positive 
cells in each slide were counted based on BrdU-stained sections by Histokat 
software (Fraunhofer MEVIS, Bremen, Germany).  
7 Statistical Analysis 
Results were expressed as mean ± standard deviation (SD). Differences between 
groups were analyzed using One-Way ANOVA by Sigmaplot 13.0 (Statcon, 
Witzenhausen, Germany).  Differences were considered significant if p-values of less 
than 0.05 were obtained (* P < 0.05). 
 
Results 
1. Body weight recovery was not affected by modulating the CXC4-CXCR7-
SDF-1 axis 
All animals tolerated the surgical procedure well. As expected, sham operated 
animals lost maximally 3.4% of their body weight and recovered fully within a week 
(Figure 1). In contrast liver resected animals experienced a maximal body weight 
loss of 8.4 % on POD 2 and recovered fully within the first 5 post-operative days 
and gained more weight thereafter. No significant difference was observed in body 
weight recovery on POD 7 between treatment groups and non-treatment groups. 
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Figure 1. Body weight recovery 
 
+ Compare 70%PH+PBS group with sham group; $ Compare 70%PH+AMD3100 with sham group;  
* Compare 70%PH group with sham group; # Compare 70%PH+TC14012 group with sham group 
 
2. Treatment with CXCR4 antagonist and CXCR7 agonist was associated with 
higher liver damage 
Sham operated animals did not show any signs of liver damage (Figure 2), as 
expected. Hepatic damage as indicated by serum ALT and AST was highest 
during the early phase (POD2) after hepatectomy. Liver enzymes reached the 
normal range within a week after resection indicating full recovery. However, 
treatment with the CXCR4 antagonist and CXCR7 agonist was associated with 
significantly higher levels of liver enzymes compared to the control group, 
suggesting a delayed recovery. In contrast, treatment with the CXCR4 antagonist 
AMD3100 only did not cause additional damage to the liver.  
 
Figure 2. Liver enzyme – serum ALT and AST  
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*p<0.05 
 
3. Treatment with CXCR4 antagonist and CXCR7 agonist was associated with 
a reduced and delayed liver weight recovery 
In the sham operated group a transient increase of LW/BW ratio (Figure 3) was 
observed. However, this was not due to an actual increase in liver weight, but due 
to the surgery induced decrease of body weight in the first 3 post-operative days. 
In contrast all liver resected animals experienced a substantial loss of the LW/BW 
ratio by POD2 as expected, which recovered thereafter. Treatment with the 
CXCR4 antagonist did not interfere with parenchymal regeneration, where the 
application of the CXCR4 antagonist and CXCR7 agonist was associated with a 
more pronounced body weight loss and a reduced and delayed recovery. It 
indicated that parenchymal liver regeneration was not affected by only blocking 
CXCR4 using AMD3100, but was impaired by simultaneous activation of CXCR7 
when applying TC14012. 
 
Figure 3. Liver weight to body weight ratio 
 
*Compare treatment group with non-treatment 70%PH group. 
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The peak proliferation index (Figure 4) on POD 2 of total BrdU positive cells was 
significantly lower in treated group (70%PH+TC14012 )compared to untreated 
70%PH group control group. It indicated that liver regeneration was impaired. 
Even on POD3, the proliferation rate remained lower in the treated group, 
indicating a prolonged impairment of liver regeneration which was also reflected in 
the lower LW/BW recovery. 
 
 
Figure 4. Proliferation index of total BrdU positive cells in 70%PH group and 
70%PH+TC14012 group at day 2 and day 3 
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4. Hepatic vascular regeneration was also affect by simultaneously blocking 
CXCR4 and activating CXCR7 
Figure 4. Visualization and quantification of vascular regeneration  
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Vascular regeneration was investigated in 70%PH+TC14012 and the untreated 
70%PH group. Treatment was associated with a substantially lower maximal vessel 
length of the RIPV at day 2 and day 7 compared to the non-treated group. It might 
indicate a delay of hepatic vascular regeneration. However, the average inflow 
vascular radii in both groups at POD 2 were rather similar. This increase of vascular 
radius at POD 2 in both groups might be better attributed to portal hypertension than 
to vascular growth (see our observation in Manuscript III). In other words, vascular 
radius could hardly reflect the effect of TC14012 to the hepatic vascular systems in 
the early post-OP time point. Vascular radius in 70%PH+TC14012 group had a 
substantial decrease at POD 7. This observation was probably due to reduced portal 
dilatation and delayed vascular expansion 
70%PH 
Naive animals
70%PH+TC14012
70%PH 
Naive animals
70%PH+TC14012
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Discussion 
In this study, we visualized and quantified hepatic parenchymal and vascular 
regeneration after modulating the CXCR4-CXCR7-SDF-1 axis. We first applied a 
CXCR4 antagonist for only blocking CXCR4 in a 70% PH mouse model. Then, we 
applied CXCR4 antagonist and CXCR7 agonist for not only blocking CXCR4 but also 
activating CXCR7 using TC14012 in the same resection model in mice.  
CXCR4 activation by SDF-1 plays an important role in modulating angiogenesis and 
haematopoiesis by acting on haematopoietic and vascular endothelial cells. Thus we 
hypothesized that the blockade of CXCR4 using AMD3100 could dampen the 
CXCL12-induced angiogenic activity and subsequent impair hepatic vascular 
regeneration in mouse liver resection model. However, blocking CXCR4 was not 
associated with any significant differences in terms of the recovery of the body weight, 
liver enzymes and LW/BW ratio or BrdU proliferation index. It indicated that blocking 
only CXCR4 using AMD3100 was apparently neither interfering with hepatic 
regeneration nor with vascular regeneration in normal mouse livers after PH.  This 
might be explained by the multiple roles of the CXCR4 blocking agent AMD3100. 
AMD3100, also known as Plerixafor, is involved in stem cell mobilization [10]. This 
role of AMD3100 might be of benefit for liver regeneration. AMD3100 also plays a 
role in suppressing inflammatory response [11] which might also play a positive role 
in tissue repair and regeneration.  
Expression of CXCR7, another chemokine receptor for SDF-1, is mainly restricted to 
endothelial cells. It is believed that the primary function of CXCR7 is pivotal in 
vascular patterning and tumor neo-angiogenesis [12]. TC14012 can activate the β-
arrestin pathway via activation of GRK, leading to internalization of CXCR4 and 
scavenging of SDF-1. Thus, we hypothesized that liver regeneration will be impaired 
by applying TC14012 via blocking CXCR4 and activating CXCR7.  
As expected, when using TC14012 we observed a slower recovery from hepatic 
injury and a slower recovery of the LW/BW ratio, indicating an impaired course of 
hepatic regeneration. This prompted to perform the next and key experiment to 
quantify vascular regeneration.  We observed a substantial delay in prolongation of 
maximal vessel length of RIPV at POD 2 in 70%PH+TC14012 group. We could 
conclude that vascular liver regeneration might be impaired as indicated by the tested 
vascular parameter of maximal vessel length. However, this difference did not yet 
reach statistical significance. . It could be explained by the small group size (n=3), the 
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observed high inter-group individual variability and vascular parameters obtained 
restrict to right inferior lobe.  
As a next step, we are going to compute the maximal vessel length for the other liver 
lobes, cumulative vascular parameters for investigating the vascular growth in the 
whole remnant liver lobes and try to enlarge the group size for reducing the individual 
variant. 
Furthermore, we are also considering todetermine the proliferation rate of 
hepatocytes and LSEC separately to get a better insight how the drug affects 
parenchymal versus vascular regeneration.  
We also observed that there was no difference in inflow vascular radius in 
70%PH+TC14012 compared to 70%PH group. Given the fact that portal 
hypertension may have residual effect to vascular radius-related parameters, the 
inflow vascular radius of RIPV was possibly not suitable for detecting the effect of a 
given drug.  
According to our results obtained in TC14012 pilot experiment, it seems that CXCR7 
is more related to liver regeneration after partial hepatectomy. It might be explained 
that CXCR7 could increase the expression of proangiogenic factors, such as 
interleukin-8 and VEGF, through a G-protein-independent β-arrestin-2-biased 
receptor resulting in ERK1/2 phosphorylation [12;13 ]. 
In summary, using our newly established workflow to assess hepatic vascular 
regeneration, we confirmed that the CXCR4-CXCR7-SDF-1 pathway is of relevance 
for liver regeneration. We identified that a substantial decrease in length and radius 
of RIPV indicated that hepatic vascular regeneration was impaired by administrating 
TC14012. Our study elucidated that blockade of CXCR4 by AMD3100 after 
hepatectomy is not capable of inhibiting angiogenesis and vascular growth, possibly 
due to compensatory actions through the alternative CXCL12 receptor CXCR7.  
In the near future, we are going to elucidate this pathway further to detect its 
molecular mechanism for better understanding the process of liver regeneration. 
Currently a pilot experiment regarding the changes in mRNA-expression of CXCR4, 
CXCR7 and SDF-1 after liver resection as detected by in situ hybridization is ongoing. 
This will serve as a basis when investigating the effects of modulating this axis.  
In conclusion, assessment of vascular regeneration by quantifying vascular growth 
and LSEC proliferation rate in addition to parenchymal regeneration is a useful add-
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on for better understanding the relevance of the CXCR4-CXCR7-SDF-1 pathway and 
liver regeneration in general. 
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4 DISCUSSION  
 
In experimental research, the 70% partial hepatectomy model in mouse model is of 
enormous importance for the study of hepatic physiology and pathophysiological 
disturbances. This liver resection model has been used for years.  
However, the mechanism of hepatic vascular regeneration still remains elusive since 
limited tools are available for studying vascular regeneration. Moreover, due to the 
small size of the mouse, technical details of determining vascular related parameters 
were rarely described.  
Thus, in the present study, we complemented technical tools for assessing hepatic 
parenchymal and vascular regeneration. We established an intraoperative monitoring 
procedure as well as a work flow from silicone injection, µCT-imaging and 
computational analysis. The results obtained using our adapted experimental 
approaches were comparable with others (Table1 in Manuscript I and Figure3 in 
Manuscript III). It indicated that these technical tools are sensitive and suitable for 
detecting differences in vascular perfusion and vascular growth. Contrasting the 
vascular tree by silicone injection and µCT scanning provided us the opportunity to 
study vascular regeneration in a qualitative and quantitative way. Ina previous study, 
we used the resulting three-dimensional vascular trees for visualizing the variations 
of hepatic vascular anatomy in normal rats and mice (Sanger et al. 2015).  
We acquired quantitative vascular parameters after µCT imaging and performed a 
quantitative analysis in 70%PH mouse model. Based on these parameters, we 
explored the growth pattern. Relating hepatic parenchymal and vascular growth as 
well as determining the similarity of branching angles suggested, at first glance, that 
regeneration resembled isotropic expansion and thus would represent an easy 
descriptive model. For further investigating of the growth pattern, a more detailed 
analysis was performed. Despite the seemingly homogeneous 3D-growth, the 
observed vascular parameters were ultimately not compatible with the hypothesis of 
isotropic expansion of liver parenchyma and vascular structures. These observations 
indicated that hepatic regeneration might be a more complex process influenced by 
many factors.  
One important factor affecting liver regeneration is portal hypertension. Portal 
hypertension induced by surgical removal of liver lobes might affect these vascular 
parameters to different extent, not only immediately after resection but also even 
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after 7 days. Based on the hepatic hemodynamic data obtained 7 days after 
resection using the established monitoring technique, we were aware of the fact that 
portal venous pressure returned to normal ranges at POD 7. However, portal 
hypertension might have residual effects on hepatic vasculature remaining for a 
longer time. In spite of this limitation, quantitative descriptions of vascular 
regeneration and, in particular, its spatial inhomogeneity, provided useful information. 
It can help to identify disturbances in liver regeneration, which is a prerequisite for 
possibly developing treatment strategies.  
Next, we applied silicone injection and micro-CT imaging technique to quantitatively 
describe hepatic vascular parameters after modulating CXCR4-CXCR7-SDF-1 
pathway in 70%PH mouse model. We observed that parenchymal and vascular liver 
regeneration were not affected by only blocking CXCR4 but were impaired by 
simultaneous activation of CXCR7 using TC14012.  
Our results elucidated that blockade of CXCR4 by AMD3100 after hepatectomy is not 
capable of inhibiting angiogenesis and vascular growth, because there might be the 
compensatory actions through the alternative SDF-1 receptor CXCR7. Substantially 
shorter maximal vessel length RIPV after administration of TC14012 might imply the 
impairment of hepatic vascular regeneration. This pilot experiment was the first step 
to study the role of CXCR4-CXCR7-SDF-1 pathway in hepatic vascular regeneration. 
It was reported that CXCR7-VEGF pathway is related to liver vascular regeneration 
(DeLeve et al. 2016). Next step, we want to investigate pure CXCR7 antagonist, such 
as CCX771 (Berahovich et al. 2014), to better understand the role of this pathway for 
liver regeneration. 
Both newly established technical tools can be used in studies evaluating vasoactive 
drugs in hepatology and hepatobiliary surgery. The monitoring procedure can be 
utilized to study the effect of drugs affecting hepatic hemodynamic parameters or 
vascular regenerative parameters. Hemodynamic data can help to characterize the 
effect of hepatobiliary procedures on the circulatory system. The workflow of silicone 
injection, µCT imaging, and visualization of the vascular tree and subsequent 
computation of selective and cumulative vascular parameter technique can be 
utilized for better understanding the kinetics of vascular growth in the progression of 
angiogenesis under normal and treatment conditions.  
In contrast to corrosion casting, the parenchyma of silicone injected liver specimen 
remains intact, so that the same specimen can be used for serial sections of the 
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whole organ for subsequent detection of molecular events during the process of 
regeneration. Assessing the spatially resolved molecular events in the vicinity of the 
regenerating vascular tree within the regenerating hepatic parenchyma is the 
prerequisite for advanced multi-scale systems biology modeling. This silicone 
injection technique is one experimental step towards reaching this goal. 3D 
visualization of molecular events in respect to the underlying vascular tree is at reach. 
Moreover, these procedures also can be applied in different vascular systems of 
other organs.  
However, the major stumbling block to the wider application of these procedures is 
the technical challenge. First, the perfusion rate for silicone injection, specifically to 
the hepatic vascular system in mice, was unknown. We successfully adapted the 
perfusion rate based on the hepatic hemodynamics measurements obtained during 
the monitoring experiments. Second, in order to master these procedures, substantial 
microsurgical experience is required. Thus, we reported critical steps in detail in the 
two published video papers to help the readers for better establishing these useful 
tools.  
In conclusion, in the present study, we successfully established two delicate 
techniques for acquiring hepatic hemodynamic parameters and parenchymal and 
vascular regenerative parameters suitable for the use in mice. Furthermore, we 
established selective and cumulative parameters suitable for quantifying the hepatic 
vascular tree and applied them for exploring the vascular growth pattern after liver 
resection. At last, we applied this technique successfully in a pilot study exploring the 
role of chemokine signaling for liver regeneration. 
Altogether our results are an important prelude to further studies on vascular 
regeneration. In the future, the techniques presented here can be applied in a broad 
range of conditions where exploration of vascular growth is needed.
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5 ABBREVIATIONS 
2D Two dimensional 
3D Three dimensional 
CAP  Carotid artery pressure 
CHA  Common hepatic artery 
CIL  Caudate inferior lobe 
CSL  Caudate superior lobe 
CVP  Central venous pressure 
Fig   Figure 
HV  Hepatic vein 
IVC  Inferior vena cava 
LLL  Left lateral lobe 
LML  Left median lobe 
LSECs Liver sinusoid endothelial cells 
ML  Median lobe 
PH  Partial hepatectomy 
POD   Postoperative day(s) 
PV  Portal vein 
PVP  Portal vein pressure 
RIL  Right inferior lobe 
RIHV  Right inferior hepatic vein 
RIPV  Right inferior portal vein 
RL  Right lobe 
RML Right median lobe 
RSL  Right superior lobe 
SD   Standard deviation   
μCT   Micro computed tomography 
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